https://curecurrent.com/trials/social-determinants-and-a-diabetes-prevention-program-tailored-for-african-americans-2001https://curecurrent.com/trials/emulation-of-the-soul-diabetes-trial-in-healthcare-claims-2002https://curecurrent.com/trials/glucose-testing-in-gdm-adherence-to-one-versus-two-hour-postprandial-glucose-monitoring-in-gestational-diabetics-2003https://curecurrent.com/trials/corneal-nerves-function-and-structure-2004https://curecurrent.com/trials/glycemic-emergency-management-gem-an-app-for-rapid-response-to-hypoglycemic-and-hyperglycemic-situations-2005https://curecurrent.com/trials/curcumin-supplementation-for-the-improvement-of-diabetes-related-outcomes-2006https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-asp1941-in-adult-patients-with-type-2-diabetes-mellitus-2007https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-asp1941-in-combination-with-metformin-in-adult-patients-with-type-2-diabetes-mellitus-2008https://curecurrent.com/trials/clinical-study-to-compare-two-skin-substitute-categories-for-their-effectiveness-to-treat-diabetic-foot-ulcers-2009https://curecurrent.com/trials/pilot-brief-communal-coping-intervention-for-adults-with-type-1-diabetes-2010https://curecurrent.com/trials/pilot-brief-communal-coping-intervention-for-adults-with-type-2-diabetes-2011https://curecurrent.com/trials/prediction-of-glycemic-response-study-2012https://curecurrent.com/trials/dietary-sodium-intake-effects-on-ertugliflozin-induced-changes-in-gfr-renal-oxygenation-and-systemic-hemodynamics-the-de-2013https://curecurrent.com/trials/4t-sustainability-program-2014https://curecurrent.com/trials/evaluation-of-a-letter-intervention-promoting-a-plant-based-diet-2015https://curecurrent.com/trials/a-multiple-ascending-dose-trial-investigating-safety-tolerability-and-pharmacokinetics-of-nnc0361-0041-2016https://curecurrent.com/trials/myelin-glia-and-depression-in-type-2-diabetes-2017https://curecurrent.com/trials/strawberries-and-risk-of-diabetes-in-adults-2018https://curecurrent.com/trials/adapting-lifestyle-offloading-for-dfus-2019https://curecurrent.com/trials/targeting-inflammation-with-salsalate-in-type-1-diabetes-neuropathy-2020https://curecurrent.com/trials/a-study-of-insulin-efsitora-alfa-ly3209590-compared-to-degludec-in-adults-with-type-2-diabetes-who-are-starting-basal-in-2021https://curecurrent.com/trials/central-mechanisms-that-regulate-glucose-metabolism-in-humans-2022https://curecurrent.com/trials/the-good-food-rx-food-as-medicine-program-2023https://curecurrent.com/trials/gastric-electrical-stimulation-ges-and-pyloroplasty-for-the-treatment-of-gastroparesis-2024https://curecurrent.com/trials/acetazolamide-in-persons-with-type-1-diabetes-dose-finding-2025https://curecurrent.com/trials/glycemic-response-in-persons-with-type-2-diabetes-mellitus-2026https://curecurrent.com/trials/insul-in-this-together-program-for-adolescents-with-type-1-diabetes-and-their-parents-2027https://curecurrent.com/trials/the-effect-of-4-weeks-of-l-citrulline-supplementation-on-macro-and-microvascular-function-in-type-2-diabetes-2028https://curecurrent.com/trials/prediabetes-stratification-by-multi-omics-profile-after-food-intake-2029https://curecurrent.com/trials/inhaled-insulin-vs-rapid-acting-injections-for-post-meal-glucose-control-in-women-with-gestational-diabetes-2030https://curecurrent.com/trials/act-intervention-for-type-2-diabetes-management-for-rural-and-underserved-community-2031https://curecurrent.com/trials/remote-glucose-monitoring-system-in-hospitalized-patients-with-diabetic-ketoacidosis-dka-2032https://curecurrent.com/trials/a-study-to-assess-efficacy-safety-of-ladarixin-in-type-1-diabetes-patients-with-preserved-ss-cell-function-at-baseline-2033https://curecurrent.com/trials/metformin-for-the-treatment-of-microvascular-dysfunction-after-gestational-diabetes-2034https://curecurrent.com/trials/avocado-snacks-in-a-prediabetic-population-2035https://curecurrent.com/trials/a-phase-1-2-study-to-evaluate-aln-khk-in-overweight-to-obese-healthy-volunteers-and-obese-patients-with-t2dm-2036https://curecurrent.com/trials/northern-manhattan-study-of-metabolism-and-mind-2037https://curecurrent.com/trials/tau-pet-imaging-in-the-northern-manhattan-study-of-metabolism-and-mind-2038https://curecurrent.com/trials/afrezza-inhale-1-study-in-pediatrics-2039https://curecurrent.com/trials/dexcom-g6-for-total-pancreatectomy-with-islet-autotransplantation-tpiat-patients-2040https://curecurrent.com/trials/comparing-the-effectiveness-of-two-approaches-to-preventing-severe-hypoglycemia-in-patients-with-type-2-diabetes-pht2-2041https://curecurrent.com/trials/orwh-scor-on-sex-and-gender-factors-affecting-women-s-incontinence-2042https://curecurrent.com/trials/effect-of-glp1-receptor-agonists-on-physical-function-body-composition-and-markers-of-aging-in-older-adults-2043https://curecurrent.com/trials/a-non-significant-risk-clinical-study-of-therapeutic-ultrasound-for-patients-with-diabetic-foot-ulcers-2044https://curecurrent.com/trials/tailored-approaches-to-reduce-distress-and-improve-self-management-for-veterans-with-diabetes-2045https://curecurrent.com/trials/targeting-the-endothelial-glycocalyx-to-enhance-vascular-function-and-exercise-induced-vascular-adaptations-in-type-2-di-2046https://curecurrent.com/trials/iowa-produce-prescription-program-2047https://curecurrent.com/trials/nutrition-focused-approach-during-cgm-initiation-a-qualitative-study-2048https://curecurrent.com/trials/a-study-to-establish-a-new-onset-hyperglycemia-and-diabetes-cohort-2049https://curecurrent.com/trials/study-to-understand-gaining-access-to-blood-glucose-records-2050https://curecurrent.com/trials/unmet-social-needs-study-2051https://curecurrent.com/trials/zibotentan-and-dapagliflozin-in-patients-with-type-2-diabetes-and-elevated-albuminuria-2052https://curecurrent.com/trials/examining-digital-health-care-delivery-models-through-medicaid-collaborative-2053https://curecurrent.com/trials/meals-for-moms-medically-tailored-meals-for-women-who-had-gestational-diabetes-2054https://curecurrent.com/trials/gluten-and-amylase-trypsin-inhibitors-ati-free-diet-2055https://curecurrent.com/trials/dynamics-of-muscle-mitochondria-in-type-2-diabetes-exercise-2056https://curecurrent.com/trials/myo-inositol-during-pregnancy-to-prevent-gestational-diabetes-2057https://curecurrent.com/trials/a-study-of-insulin-efsitora-alfa-ly3209590-as-a-weekly-basal-insulin-compared-to-insulin-glargine-in-adult-participants-2058https://curecurrent.com/trials/rural-area-pharmacist-intervention-for-diabetes-2059https://curecurrent.com/trials/a-phase-1b-study-to-assess-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-doses-of-jnj-64565111-i-2060https://curecurrent.com/trials/development-of-an-adaptive-treatment-for-weight-loss-in-people-with-prediabetes-2061https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-canagliflozin-in-children-and-adolescents-10-to-18-years-with-type-2-d-2062https://curecurrent.com/trials/role-of-neuraminidase-activity-on-endothelial-dysfunction-in-type-2-diabetes-2063https://curecurrent.com/trials/dapagliflozin-treatment-in-type-2-diabetes-2064https://curecurrent.com/trials/carbohydrate-beta-cell-function-and-glucose-control-in-children-with-diabetes-2065https://curecurrent.com/trials/the-hope-app-study-2066https://curecurrent.com/trials/treatment-burden-screening-questionnaire-pilot-study-2067https://curecurrent.com/trials/feasibility-of-yoga-for-type-2-diabetes-2068https://curecurrent.com/trials/mhealth-smartphone-app-and-postpartum-glucose-intolerance-for-patients-with-gdm-2069https://curecurrent.com/trials/long-term-follow-up-study-of-advm-022-in-dme-infinity-ext-2070https://curecurrent.com/trials/a-pragmatic-approach-to-lower-diabetes-risk-after-gestational-diabetes-2071https://curecurrent.com/trials/liraglutide-in-adolescents-with-type-1-diabetes-2072https://curecurrent.com/trials/screening-for-sacral-agenesis-in-offspring-of-mothers-with-diabetes-in-pregnancy-2073https://curecurrent.com/trials/omnipod-5-automated-insulin-delivery-system-in-patients-with-type-2-diabetes-2074https://curecurrent.com/trials/best-practice-advisories-to-reduce-inequities-in-technology-use-for-people-with-type-1-diabetes-2075https://curecurrent.com/trials/personalized-responses-to-dietary-composition-trial-3-2076https://curecurrent.com/trials/benefits-of-insoles-with-real-time-alert-and-foot-self-care-education-2077https://curecurrent.com/trials/metformin-versus-standard-of-care-treatment-in-pregnant-women-with-prediabetes-2078https://curecurrent.com/trials/closed-loop-context-aware-aid-2079https://curecurrent.com/trials/the-beet-diabetes-feasibility-trial-2080https://curecurrent.com/trials/diabetes-education-and-care-for-deaf-populations-2081https://curecurrent.com/trials/a-dose-escalation-and-expansion-study-of-giga-564-in-participants-with-locally-advanced-or-metastatic-solid-tumor-malign-2082https://curecurrent.com/trials/effects-of-a-patient-portal-intervention-to-address-diabetes-care-gaps-2083https://curecurrent.com/trials/non-proliferative-diabetic-retinopathy-treated-with-runcaciguat-2084https://curecurrent.com/trials/continuous-glucose-monitoring-for-hyperglycemia-in-critically-ill-patients-2085https://curecurrent.com/trials/afrezza-with-basal-combination-abc-afrezza-combined-with-aid-pump-or-insulin-degludec-in-adults-with-type-1-diabetes-2086https://curecurrent.com/trials/validation-of-the-diabetes-deep-neural-network-score-for-diabetes-mellitus-screening-2087https://curecurrent.com/trials/home-based-kidney-care-in-native-american-s-of-new-mexico-hbkc-2088https://curecurrent.com/trials/incorporating-mind-body-skills-with-diabetes-education-in-adolescents-with-type-1-diabetes-2089https://curecurrent.com/trials/ai-ready-and-exploratory-atlas-for-diabetes-insights-2090https://curecurrent.com/trials/comparative-effectiveness-of-diabetes-shared-medical-appointment-models-2091https://curecurrent.com/trials/group-emotion-focused-behavioral-intervention-for-diabetes-distress-a1c-in-t2d-2092https://curecurrent.com/trials/repository-of-novel-analytes-leading-to-autoimmune-inflammatory-and-diabetic-nephropathies-renal-aid-2093https://curecurrent.com/trials/methylglyoxal-evaluation-in-humans-2094https://curecurrent.com/trials/evaluating-a-type-2-diabetes-prevention-program-2095https://curecurrent.com/trials/project-whade-a-partner-based-physical-activity-program-for-women-2096https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-a-purified-native-type-1-collagen-extracellular-matrix-with-polyhexamethylene-biguan-2097https://curecurrent.com/trials/low-dose-pioglitazone-in-patients-with-nash-aim-2-2098https://curecurrent.com/trials/project-to-improve-communication-about-serious-illness-hospital-study-pragmatic-trial-trial-1-2099https://curecurrent.com/trials/team-clinic-virtual-expansion-of-an-innovative-multi-disciplinary-care-model-for-adolescents-and-young-adults-with-type-2100https://curecurrent.com/trials/community-based-nutrition-lifestyle-therapy-for-pregnant-latina-women-with-diabetes-2101https://curecurrent.com/trials/pivotal-omnipod-horizon-automated-glucose-control-system-2102https://curecurrent.com/trials/assessing-open-access-audio-2103https://curecurrent.com/trials/control-iq-technology-for-high-insulin-users-with-type-1-diabetes-higher-iq-2104https://curecurrent.com/trials/short-interval-resveratrol-trial-in-cardiovascular-surgery-2105https://curecurrent.com/trials/the-acute-t-rex-timing-of-resistance-exercise-study-2106https://curecurrent.com/trials/tailoring-ot-and-rd-services-for-home-delivered-meal-clients-2107https://curecurrent.com/trials/evaluate-hm-002-1005-in-subjects-with-type-2-diabetes-mellitus-2108https://curecurrent.com/trials/integrating-abbott-point-of-care-technologies-and-the-community-scientist-model-to-support-hba1c-testing-per-ada-2109https://curecurrent.com/trials/personalized-patient-data-and-behavioral-nudges-to-improve-adherence-to-chronic-cardiovascular-medications-2110https://curecurrent.com/trials/below-the-knee-interventions-for-limb-salvage-use-of-multifunctional-angioplasty-balloon-catheters-2111https://curecurrent.com/trials/population-health-management-for-kpnc-members-with-newly-diagnosed-diabetes-a-randomized-trial-of-a-proactive-and-augmen-2112https://curecurrent.com/trials/matrion-decellularized-placental-membrane-in-subjects-with-diabetic-foot-ulcers-2113https://curecurrent.com/trials/radiotracer-based-perfusion-imaging-of-patients-with-peripheral-arterial-disease-2114https://curecurrent.com/trials/ticagrelor-with-and-without-aspirin-in-patients-with-diabetes-mellitus-2115https://curecurrent.com/trials/effect-of-postprandial-hyperglycemia-on-vasculature-in-type-1-diabetes-and-healthy-adults-2116https://curecurrent.com/trials/trial-to-assess-chelation-therapy-2-2117https://curecurrent.com/trials/metabolic-and-renal-effects-of-automated-insulin-delivery-systems-in-youth-with-type-1-diabetes-mellitus-2118https://curecurrent.com/trials/glucose-variability-and-cognition-in-prediabetes-2119https://curecurrent.com/trials/a-study-to-assess-ct-868-and-the-relationship-between-insulin-secretory-response-and-ambient-blood-glucose-2120https://curecurrent.com/trials/reducing-cardiometabolic-risk-and-promoting-functional-health-in-older-adults-with-obesity-and-prediabetes-2121https://curecurrent.com/trials/pancreatic-enzyme-replacement-and-glucose-regulation-in-type-1-diabetes-2122https://curecurrent.com/trials/randomized-trial-of-supplemental-synchronous-and-asynchronous-telehealth-to-improve-glycemic-control-for-pediatric-patie-2123https://curecurrent.com/trials/technology-delivered-physical-activity-program-for-adolescents-with-type-1-diabetes-2124https://curecurrent.com/trials/cgm-as-diagnostic-tool-in-observing-steroid-induced-hyperglycemia-2125https://curecurrent.com/trials/extending-dental-care-to-nursing-home-residents-to-reduce-mouth-infections-and-incidence-of-pneumonia-and-improve-diabet-2126https://curecurrent.com/trials/ignite-impact-of-glucose-monitoring-and-nutrition-on-time-in-range-2127https://curecurrent.com/trials/effect-of-corticosteroid-injections-on-blood-glucose-2128https://curecurrent.com/trials/implementing-continuous-glucose-monitoring-in-primary-care-for-patients-with-diabetes-2129https://curecurrent.com/trials/clinical-effectiveness-of-body-fat-distribution-imaging-in-real-world-practice-the-body-real-study-2130https://curecurrent.com/trials/drug-interaction-study-between-dorzagliatin-and-empagliflozin-2131https://curecurrent.com/trials/puberty-diabetes-and-the-kidneys-when-eustress-becomes-distress-panther-study-2132https://curecurrent.com/trials/food-as-medicine-study-2133https://curecurrent.com/trials/impact-of-remote-foot-temperature-monitoring-2134https://curecurrent.com/trials/a-study-of-autologous-renal-autologous-cell-therapy-react-in-patients-with-diabetic-chronic-kidney-disease-2135https://curecurrent.com/trials/randomized-trial-of-exercise-promotion-in-primary-care-2136https://curecurrent.com/trials/diabetes-functional-medicine-approach-vs-usual-care-2137https://curecurrent.com/trials/positive-psychology-intervention-to-treat-diabetes-distress-in-teens-with-type-1-diabetes-2138https://curecurrent.com/trials/reducing-treatment-risk-in-older-adults-with-diabetes-2139https://curecurrent.com/trials/switch-diets-study-self-monitoring-with-internet-technology-to-choose-healthy-diets-2140https://curecurrent.com/trials/capability-assessment-for-diet-and-activity-cada-model-for-diabetes-2141https://curecurrent.com/trials/impact-of-somasignal-tests-on-the-choice-of-glucose-lowering-medications-2142https://curecurrent.com/trials/postpartum-continuous-glucose-monitoring-cgm-study-2143https://curecurrent.com/trials/comparing-semaglutide-versus-placebo-on-intestinal-barrier-function-in-type-2-diabetes-mellitus-sib-2144https://curecurrent.com/trials/a-research-study-to-see-how-semaglutide-works-compared-to-placebo-in-people-with-type-2-diabetes-and-chronic-kidney-dise-2145https://curecurrent.com/trials/my-diabetes-care-a-scalability-and-usability-study-2146https://curecurrent.com/trials/complete-health-improvement-program-for-geisinger-health-plan-members-with-type-2-diabetes-2147https://curecurrent.com/trials/resistance-exercise-and-low-intensity-physical-activity-breaks-in-sedentary-time-to-improve-muscle-and-cardiometabolic-h-2148https://curecurrent.com/trials/platelet-par-1-activation-in-health-and-diabetes-2149https://curecurrent.com/trials/technology-based-sedentary-reduction-intervention-in-patients-with-type-2-diabetes-2150https://curecurrent.com/trials/gastric-volume-in-patients-on-glp-1-medications-2151https://curecurrent.com/trials/efficacy-and-safety-of-aeye-diagnostic-screening-aeye-ds-software-device-for-detection-of-diabetic-retinopathy-from-digi-2152https://curecurrent.com/trials/cooking-for-health-2153https://curecurrent.com/trials/a-study-to-investigate-multiple-ascending-doses-and-relative-bioavailability-of-azd5004-in-healthy-participants-2154https://curecurrent.com/trials/the-role-of-type-2-diabetes-on-skeletal-muscle-atrophy-and-recovery-following-bed-rest-in-older-adults-2155https://curecurrent.com/trials/treatment-to-regress-to-normoglycemia-in-women-with-a-recent-history-of-gdm-2156https://curecurrent.com/trials/impact-of-colorectal-cancer-and-nutrition-education-program-among-minority-patients-with-type-2-diabetes-2157https://curecurrent.com/trials/sit-less-program-for-patients-with-type-2-diabetes-2158https://curecurrent.com/trials/vestibular-stimulation-to-trigger-adipose-loss-vestal-clinical-trial-2159https://curecurrent.com/trials/choline-supplementation-on-fetal-growth-in-gestational-diabetes-mellitus-2160https://curecurrent.com/trials/a-research-study-to-see-how-much-semaglutide-and-snac-is-in-the-milk-of-healthy-breastfeeding-women-taking-semaglutide-t-2161https://curecurrent.com/trials/virta-intervention-in-communities-in-colorado-victor-pilot-2162https://curecurrent.com/trials/effect-of-fiber-supplementation-on-the-need-for-medication-with-gestational-diabetes-2163https://curecurrent.com/trials/a-phase-2a-proof-of-concept-open-label-randomized-controlled-study-to-evaluate-the-safety-and-efficacy-of-mdi-1228-mesyl-2164https://curecurrent.com/trials/effect-of-at-derived-mirna-on-the-biology-and-insulin-sensitivity-of-skeletal-muscle-in-humans-2165https://curecurrent.com/trials/a-study-of-cgrp-monoclonal-antibody-to-treat-diabetic-neuropathy-2166https://curecurrent.com/trials/the-men-are-now-united-program-2167https://curecurrent.com/trials/my-essence-a-research-study-on-mindfulness-for-african-americans-with-type-2-diabetes-2168https://curecurrent.com/trials/safety-tolerability-and-potential-efficacy-of-avt001-in-patients-with-type-1-diabetes-2169https://curecurrent.com/trials/acute-effects-of-canagliflozin-a-sodium-glucose-co-transporter-2-sglt2-inhibitor-on-bone-metabolism-in-healthy-volunteer-2170https://curecurrent.com/trials/home-based-kidney-care-in-native-americans-of-new-mexico-hbkc-enhancement-covid-19-study-2171https://curecurrent.com/trials/the-role-of-acute-combined-ppar-alpha-and-gamma-stimulation-on-insulin-action-in-humans-2172https://curecurrent.com/trials/nyscf-scientific-discovery-biobank-2173https://curecurrent.com/trials/better-together-study-2174https://curecurrent.com/trials/cardiovascular-risk-screening-and-risk-reduction-in-women-vets-2175https://curecurrent.com/trials/a-study-of-participants-with-chronic-kidney-disease-previously-treated-with-react-2176https://curecurrent.com/trials/combining-shockwave-therapy-and-platelet-rich-plasma-to-treat-erectile-dysfunction-in-diabetic-men-cocktail-dm-2177https://curecurrent.com/trials/safety-and-efficacy-of-oral-gkt137831-in-patient-with-type-2-diabetes-and-albuminuria-2178https://curecurrent.com/trials/a-phase-1-2-safety-study-of-intratumorally-dosed-int230-6-2179https://curecurrent.com/trials/clinical-outcomes-related-to-treatment-of-distal-symmetric-polyneuropathy-using-semiconductor-embedded-therapeutic-socks-2180https://curecurrent.com/trials/alternate-measures-of-glucose-during-ogtt-testing-for-cfrd-2181https://curecurrent.com/trials/evaluation-of-the-performance-of-contour-next-and-contour-plus-elite-bgms-in-neonates-using-capillary-blood-samples-2182https://curecurrent.com/trials/oral-hypoglycemic-therapy-for-monogenic-variant-carriers-of-the-joslin-medalist-study-2183https://curecurrent.com/trials/ketone-monitoring-in-t1d-effect-of-sglt2i-during-usual-care-and-with-insulin-deficiency-2184https://curecurrent.com/trials/advancing-understanding-of-transportation-options-2185https://curecurrent.com/trials/metabolism-of-low-carbohydrate-and-ketogenic-diet-2186https://curecurrent.com/trials/the-insulin-only-bionic-pancreas-pivotal-trial-2187https://curecurrent.com/trials/a-mobile-health-intervention-to-reduce-diabetes-disparities-in-chinese-americans-2188https://curecurrent.com/trials/i-matter-investigating-an-mhealth-texting-tool-for-embedding-patient-reported-data-into-diabetes-management-2189https://curecurrent.com/trials/transition-from-basal-bolus-to-once-weekly-subcutaneous-semaglutide-and-basal-insulin-in-patients-with-t2d-2190https://curecurrent.com/trials/safety-and-effectiveness-of-the-minimed-780g-system-with-ds5-cgm-2191https://curecurrent.com/trials/estrogen-and-diabetes-2192https://curecurrent.com/trials/predicting-diabetic-retinopathy-from-risk-factor-data-and-digital-retinal-images-2193https://curecurrent.com/trials/bioenergetics-and-metabolism-in-pediatric-populations-2194https://curecurrent.com/trials/immunometabolism-in-pediatric-obesity-2195https://curecurrent.com/trials/social-support-intervention-for-older-adults-with-t2dm-2196https://curecurrent.com/trials/comparative-effectiveness-of-family-vs-individually-focused-diabetes-education-and-support-2197https://curecurrent.com/trials/game-based-pediatric-diabetes-education-2198https://curecurrent.com/trials/mechanisms-for-restoration-of-hypoglycemia-awareness-2199https://curecurrent.com/trials/unsweetened-sparkling-water-and-changes-in-sweetness-perception-in-adolescents-2200https://curecurrent.com/trials/at-risk-for-type-1-diabetes-extension-study-tn-10-extension-2201https://curecurrent.com/trials/administration-of-hydroxychloroquine-plaquenil-to-african-americans-and-hispanics-for-the-treatment-of-mild-to-severe-ul-2202https://curecurrent.com/trials/study-to-determine-the-efficacy-of-real-time-cgm-in-preventing-hypoglycemia-among-insulin-treated-patients-with-dm2-on-h-2203https://curecurrent.com/trials/a-study-evaluating-the-safety-tolerability-and-pharmacodynamic-effects-of-gly-200-in-type-2-diabetic-patients-2204https://curecurrent.com/trials/rising-tide-amniotic-tissue-s-treatments-for-chronic-diabetic-foot-ulcers-2205https://curecurrent.com/trials/food-assistance-diabetes-and-hiv-2206https://curecurrent.com/trials/the-medically-reproducing-bariatric-surgery-mrb-ii-study-2207https://curecurrent.com/trials/communication-and-coping-for-mothers-of-adolescents-with-type-1-diabetes-2208https://curecurrent.com/trials/integrate-d-a-pilot-test-to-support-integration-of-medical-and-psychosocial-care-for-people-with-type-ii-diabetes-2209https://curecurrent.com/trials/feasibility-trial-of-a-mindfulness-based-intervention-in-youth-with-type-1-diabetes-2210https://curecurrent.com/trials/implementation-and-evaluation-of-a-diabetes-prevention-clinical-pathway-in-primary-care-2211https://curecurrent.com/trials/glycemic-control-and-treatment-satisfaction-using-finesse-versus-pen-for-initiating-bolus-insulin-dosing-in-type-2-diabe-2212https://curecurrent.com/trials/a-study-of-simponi-to-arrest-beta-cell-loss-in-type-1-diabetes-2213https://curecurrent.com/trials/feasibility-study-of-finesse-for-bolus-prandial-insulin-dosing-compared-to-multiple-daily-injections-2214https://curecurrent.com/trials/isoleucine-intake-and-intermediary-metabolism-in-type-2-diabetes-2215https://curecurrent.com/trials/community-intervention-to-improve-cvd-risk-factor-control-in-young-american-indians-2216https://curecurrent.com/trials/a-study-to-evaluate-simponi-golimumab-therapy-in-children-adolescents-and-young-adults-with-pre-symptomatic-type-1-diabe-2217https://curecurrent.com/trials/feasibility-study-assessing-the-ability-of-an-insulin-pump-controlling-algorithm-to-minimize-hypoglycemia-and-hyperglyce-2218https://curecurrent.com/trials/a-cognitive-behavioral-intervention-to-reduce-fear-of-hypoglycemia-in-young-adults-with-type-1-diabetes-2219https://curecurrent.com/trials/intravitreal-injection-site-and-perceived-pain-2220https://curecurrent.com/trials/diabetic-cardiomyopathy-and-heart-failure-2221https://curecurrent.com/trials/targeting-hyaluronan-accumulation-through-exercise-in-t2dm-2222https://curecurrent.com/trials/mobile-app-logging-for-diabetes-in-pregnancy-2223https://curecurrent.com/trials/effect-of-metreleptin-therapy-in-the-treatment-of-severe-insulin-resistance-2224https://curecurrent.com/trials/dehydrated-human-amnion-membrane-and-standard-of-care-versus-standard-of-care-alone-in-nonhealing-diabetic-foot-ulcers-2225https://curecurrent.com/trials/evaluation-of-flash-continuous-glucose-monitoring-to-reduce-hyperglycemia-in-people-with-t2-diabetes-2226https://curecurrent.com/trials/assessing-accuracy-of-the-freestyle-libre-pro-glucose-monitoring-in-patients-with-diabetes-in-a-critical-care-setting-2227https://curecurrent.com/trials/preventing-medication-mismanagement-in-people-living-with-dementia-through-automated-medication-dispensing-with-facial-r-2228https://curecurrent.com/trials/t2-fsl2-weight-loss-2229https://curecurrent.com/trials/efficacy-of-viome-s-precision-nutrition-program-towards-reducing-hba1c-2230https://curecurrent.com/trials/type-1-diabetes-endothelin-and-skeletal-muscle-mitochondrial-dysfunction-the-role-of-sirtuin-1-2231https://curecurrent.com/trials/study-for-multiple-doses-of-hm15136-efpegerglucagon-in-obese-or-overweight-subjects-with-comorbidities-2232https://curecurrent.com/trials/intra-portal-alone-versus-intra-and-extra-portal-transplantation-of-pancreatic-islets-after-total-pancreatectomy-for-chr-2233https://curecurrent.com/trials/measuring-the-priorities-of-patients-with-type-ii-diabetes-using-likert-scale-and-best-worst-scaling-2234https://curecurrent.com/trials/heat-shock-therapy-to-improve-mitochondrial-function-in-neuropathy-2235https://curecurrent.com/trials/aqueous-biomarker-levels-in-diabetic-retinopathy-and-diabetic-macular-edema-2236https://curecurrent.com/trials/efficacy-of-viome-s-precision-nutrition-program-towards-reducing-hba1c-2237https://curecurrent.com/trials/eo2-oxygen-delivery-to-study-success-rate-of-surgically-closed-wounds-2238https://curecurrent.com/trials/clinical-study-of-allo-asc-sheet-in-subjects-with-diabetic-foot-ulcers-2239https://curecurrent.com/trials/long-term-efficacy-and-safety-of-intravitreal-aflibercept-injections-for-the-treatment-of-diabetic-retinopathy-for-subje-2240https://curecurrent.com/trials/native-american-diabetes-project-2241https://curecurrent.com/trials/cohere-contextualized-care-in-chcs-electronic-health-records-2242https://curecurrent.com/trials/study-to-determine-the-prevalence-of-hypercortisolism-in-patients-with-type-2-diabetes-and-treatment-with-korlym-mifepri-2243https://curecurrent.com/trials/modified-multi-platform-trial-assessing-multiple-camps-and-soc-vs-soc-alone-in-the-treatment-of-dfu-and-vlus-2244https://curecurrent.com/trials/effects-of-niacin-on-intramyocellular-fatty-acid-trafficking-in-upper-body-obesity-and-type-2-diabetes-mellitus-2245https://curecurrent.com/trials/latinos-understanding-the-need-for-adherence-in-diabetes-using-e-health-2246https://curecurrent.com/trials/gdm-insulin-with-or-without-metformin-2247https://curecurrent.com/trials/fetal-cardiac-function-parameters-and-hba1c-as-screening-for-gestational-diabetes-mellitus-2248https://curecurrent.com/trials/islet-allotransplantation-in-type-1-diabetes-2249https://curecurrent.com/trials/study-of-harmine-in-healthy-subjects-2250https://curecurrent.com/trials/the-elg-analysis-of-glucose-a-correlational-to-blood-glucose-assay-2251https://curecurrent.com/trials/evaluation-of-the-advanced-hybrid-closed-loop-ahcl-system-in-type-1-adults-and-pediatrics-utilizing-lyumjev-2252https://curecurrent.com/trials/celliant-socks-to-increase-tissue-oxygenation-and-complete-wound-closure-in-diabetic-foot-wounds-2253https://curecurrent.com/trials/automated-insulin-delivery-in-elderly-with-type-1-diabetes-aide-t1d-2254https://curecurrent.com/trials/prolongation-of-glp-1-adherence-when-using-continuous-glucose-monitoring-2255https://curecurrent.com/trials/safety-evaluation-of-the-advanced-hybrid-closed-loop-ahcl-system-2256https://curecurrent.com/trials/a-study-of-ly3493269-in-participants-with-type-2-diabetes-2257https://curecurrent.com/trials/reversibility-of-brain-glucose-transport-in-type-2-diabetes-mellitus-t2dm-2258https://curecurrent.com/trials/diabetes-prevention-program-feasibility-study-of-breastfeeding-2259https://curecurrent.com/trials/the-prevalence-of-autoimmune-antibodies-in-patients-with-type-2-diabetes-managed-by-endocrinology-vs-primary-care-2260https://curecurrent.com/trials/continuous-glucose-monitoring-and-diabetes-2261https://curecurrent.com/trials/hyperglycemia-and-mitochondrial-function-in-the-endothelium-of-humans-2262https://curecurrent.com/trials/clinical-trial-evaluating-an-amnion-membrane-allograft-for-use-in-the-management-of-non-healing-diabetic-foot-ulcers-ver-2263https://curecurrent.com/trials/perioperative-glucose-monitoring-and-treatment-to-reduce-risk-of-surgical-site-infections-and-complications-2264https://curecurrent.com/trials/somasignal-tests-on-medical-management-and-change-in-risk-in-patients-with-diabetes-2265https://curecurrent.com/trials/dextrose-gel-does-not-prevent-neonatal-hypoglycemia-2266https://curecurrent.com/trials/improving-diabetic-patient-health-through-assistive-reading-technology-2267https://curecurrent.com/trials/metabolic-study-of-women-with-polycystic-ovary-syndrome-and-sleep-apnea-2268https://curecurrent.com/trials/kerecis-real-world-fish-skin-graft-registry-2269https://curecurrent.com/trials/a-study-to-assess-the-effects-of-ct-868-treatment-on-glucose-homeostasis-in-participants-with-type-1-diabetes-2270https://curecurrent.com/trials/digital-diabetes-prevention-program-study-2271https://curecurrent.com/trials/study-to-assess-the-safety-of-dermaseal-for-diabetic-foot-ulcers-2272https://curecurrent.com/trials/clinical-trial-assessing-human-placental-membrane-products-and-standard-of-care-versus-standard-of-care-in-nonhealing-df-2273https://curecurrent.com/trials/improving-detection-and-evidence-based-care-of-nafld-in-latinx-and-black-patients-with-type-2-diabetes-2274https://curecurrent.com/trials/scaling-community-clinical-linkage-models-to-address-diabetes-and-hypertension-disparities-in-the-southeast-united-state-2275https://curecurrent.com/trials/immunonutrition-for-diabetic-foot-ulcers-2276https://curecurrent.com/trials/hypoglycemia-prevention-in-high-risk-type-2-diabetes-patients-2277https://curecurrent.com/trials/use-of-control-iq-technology-2-0-in-adults-children-and-preschoolers-with-type-1-diabetes-2278https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-azd5718-in-participants-with-proteinuric-chronic-kidney-disease-2279https://curecurrent.com/trials/clinical-evaluation-of-the-pharmacokinetic-goldenseal-metformin-interaction-in-diabetic-patients-2280https://curecurrent.com/trials/very-low-carbohydrate-diets-and-glucagon-response-in-t1dm-2281https://curecurrent.com/trials/enhancing-preventative-health-behaviors-among-emergency-department-hyperglycemic-patients-2282https://curecurrent.com/trials/fully-closed-loop-at-home-fcl-home-2283https://curecurrent.com/trials/type-1-diabetes-management-using-a-very-low-carbohydrate-versus-standard-diet-2284https://curecurrent.com/trials/postpartum-glycemia-in-women-at-risk-for-persistent-hyperglycemia-2285https://curecurrent.com/trials/effects-of-ketosis-on-brain-function-in-patients-with-t1dm-2286https://curecurrent.com/trials/comparing-program-options-for-latinos-with-diabetes-2287https://curecurrent.com/trials/food-and-resources-expanded-to-support-health-and-type-2-diabetes-2288https://curecurrent.com/trials/feasibility-of-the-camp-power-up-program-on-children-s-body-weight-and-quality-of-life-2289https://curecurrent.com/trials/embecta-aid-system-in-adults-with-type-2-diabetes-2290https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-adults-with-type-2-diabetes-switching-from-a-glp-1-ra-surpass-switch-2-2291https://curecurrent.com/trials/a-study-to-assess-safety-tolerability-and-pharmacokinetics-of-azd0186-2292https://curecurrent.com/trials/metabolic-phenotypes-and-heterogeneity-in-disease-burden-risk-in-type-1-diabetes-2293https://curecurrent.com/trials/regulation-of-insulin-secretion-by-the-glp-1-receptor-2294https://curecurrent.com/trials/personalizing-self-management-in-diabetes-pilot-study-2295https://curecurrent.com/trials/using-simplified-meal-boluses-versus-carbohydrate-counting-in-adolescents-with-hybrid-closed-loop-systems-2296https://curecurrent.com/trials/microlearning-application-for-diabetes-prevention-2297https://curecurrent.com/trials/use-of-the-guardian-connect-system-with-smart-connected-devices-2298https://curecurrent.com/trials/using-wearable-sensors-to-understand-low-blood-sugar-in-type-1-diabetes-2299https://curecurrent.com/trials/integrated-care-ic-models-for-patient-centered-outcomes-2300https://curecurrent.com/trials/diabetes-self-management-plus-tai-chi-easy-2301https://curecurrent.com/trials/the-wise-weightloss-intervention-surgical-effects-brain-study-2302https://curecurrent.com/trials/acceptability-impact-of-a-diabetes-management-smartphone-app-mysugr-for-spanish-literate-adults-with-type-2-diabetes-2303https://curecurrent.com/trials/pilot-of-pragmatic-delivery-of-behavioral-approaches-to-reduce-diabetes-distress-in-adults-with-type-1-diabetes-2304https://curecurrent.com/trials/glp-1-therapy-the-role-of-il-6-signaling-and-adipose-tissue-remodeling-in-metabolic-response-2305https://curecurrent.com/trials/integrating-the-genetic-and-metabolic-faces-of-obesity-2306https://curecurrent.com/trials/benefits-of-nutritional-ingredients-for-type-2-diabetes-2307https://curecurrent.com/trials/regional-fat-depots-and-insulin-resistance-2308https://curecurrent.com/trials/longitudinal-multi-omic-profiles-to-reveal-mechanisms-of-obesity-mediated-insulin-resistance-2309https://curecurrent.com/trials/a-safety-tolerability-and-efficacy-study-of-vc-02-combination-product-in-subjects-with-type-1-diabetes-mellitus-and-hypo-2310https://curecurrent.com/trials/the-true-vie-i3-continuous-glucose-monitoring-system-in-pediatric-patients-with-type-1-diabetes-mellitus-2311https://curecurrent.com/trials/social-network-analysis-to-identify-community-health-workers-2312https://curecurrent.com/trials/metatarsal-phalangeal-joint-deformity-progression-r01-2313https://curecurrent.com/trials/a-prospective-open-label-multicenter-trial-for-evaluating-the-efficacy-of-treating-and-managing-wounds-in-elderly-popula-2314https://curecurrent.com/trials/cognitive-training-for-diabetes-self-management-2315https://curecurrent.com/trials/metabolic-analysis-for-treatment-choice-in-gestational-diabetes-mellitus-2316https://curecurrent.com/trials/measuring-the-preferences-of-patients-with-type-ii-diabetes-using-best-worst-scaling-and-discrete-choice-experiment-2317https://curecurrent.com/trials/behavioral-economics-and-self-determination-theory-to-change-diabetes-risk-best-change-2318https://curecurrent.com/trials/family-routines-enhancing-adolescent-diabetes-by-optimizing-management-2319https://curecurrent.com/trials/hybrid-closed-loop-therapy-and-verapamil-for-beta-cell-preservation-in-new-onset-type-1-diabetes-2320https://curecurrent.com/trials/ocular-safety-and-usability-study-for-fyb203-pfs-2321https://curecurrent.com/trials/miracle-of-life-study-2322https://curecurrent.com/trials/time-restricted-eating-for-the-treatment-of-type-2-diabetes-2323https://curecurrent.com/trials/cgm-clarity-use-glycemic-control-and-clinical-outcomes-2324https://curecurrent.com/trials/sleep-duration-in-women-with-previous-gestational-diabetes-2325https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-therapeutic-activity-of-gi-102-as-a-single-agent-and-in-combination-with-conventional-2326https://curecurrent.com/trials/healthy-living-for-you-2327https://curecurrent.com/trials/mastering-diabetes-study-2328https://curecurrent.com/trials/strict-versus-permissive-thresholds-for-initiation-of-pharmacotherapy-in-gestational-diabetes-start-2-2329https://curecurrent.com/trials/pilot-trial-of-a-novel-cooking-skills-intervention-dppcooks-to-prevent-diabetes-2330https://curecurrent.com/trials/dilapan-s-a-multicenter-us-e-registry-2331https://curecurrent.com/trials/strict-versus-permissive-thresholds-for-initiation-of-pharmacotherapy-in-gestational-diabetes-2332https://curecurrent.com/trials/a-study-of-bi-765128-in-patients-with-an-eye-condition-called-diabetic-macular-ischemia-who-have-received-laser-treatmen-2333https://curecurrent.com/trials/health-beliefs-glycemic-control-and-preventing-cognitive-decline-in-african-americans-with-diabetes-and-mild-cognitive-i-2334https://curecurrent.com/trials/real-world-evidence-with-the-debritom-tm-novel-micro-water-jet-technology-at-a-single-wound-center-2335https://curecurrent.com/trials/a-12-month-site-randomized-trial-in-adults-with-type-2-diabetes-mellitus-and-history-of-cardiovascular-disease-2336https://curecurrent.com/trials/a-unique-micro-water-jet-technology-device-versus-standard-debridement-in-the-treatment-of-diabetic-foot-2337https://curecurrent.com/trials/healthy-liver-healthy-brain-2338https://curecurrent.com/trials/effect-of-a-pharmacist-led-collaborative-practice-on-clinical-outcomes-in-persons-with-diabetes-2339https://curecurrent.com/trials/evaluating-the-efficacy-of-a-single-layer-placental-based-allograft-and-standard-of-care-versus-standard-of-care-2340https://curecurrent.com/trials/effect-of-mango-consumption-on-individuals-with-pre-diabetes-2341https://curecurrent.com/trials/p20-extending-sleep-to-reverse-metabolic-syndrome-2342https://curecurrent.com/trials/ymca-produce-prescription-project-yprx-2343https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-azd9977-and-dapagliflozin-in-participants-with-heart-failure-and-chronic-kidney-dise-2344https://curecurrent.com/trials/metformin-compared-to-glyburide-in-gestational-diabetes-2345https://curecurrent.com/trials/addressing-diffusion-of-responsibility-and-prescribing-burden-to-improve-use-of-diabetes-medications-2346https://curecurrent.com/trials/vdpp-facilitated-with-community-care-coordination-2347https://curecurrent.com/trials/tre-with-physical-activity-for-weight-management-2348https://curecurrent.com/trials/study-of-enterra-programming-with-nocturnal-cycling-in-gastroparetics-2349https://curecurrent.com/trials/physical-activity-and-sedentary-behavior-change-impact-on-lifestyle-2350https://curecurrent.com/trials/study-of-enhanced-programming-stimulation-with-the-enterra-therapy-system-2351https://curecurrent.com/trials/the-grade-capillary-blood-collection-pilot-study-2352https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-asp1941-in-adults-with-type-2-diabetes-mellitus-2353https://curecurrent.com/trials/web-based-simulation-tool-for-self-management-support-in-type-1-diabetes-mellitus-2354https://curecurrent.com/trials/heterogeneity-of-diabetes-integrated-muli-omics-to-identify-physiologic-subphenotypes-and-evaluate-targeted-prevention-2355https://curecurrent.com/trials/wound-assessment-using-spectral-imaging-us-2356https://curecurrent.com/trials/comparison-of-intraoperative-best-practice-advisory-reminders-to-protocolize-insulin-administration-versus-standard-care-2357https://curecurrent.com/trials/glp-1-ra-ultrasound-study-2358https://curecurrent.com/trials/adi-peg20-obesity-and-prediabetes-2359https://curecurrent.com/trials/veteran-support-and-resources-for-diabetes-2360https://curecurrent.com/trials/adaptive-biobehavioral-control-abc-of-automated-insulin-delivery-2361https://curecurrent.com/trials/diabetes-homeless-medication-support-2362https://curecurrent.com/trials/combined-behavioral-and-pharmacological-intervention-for-cardiovascular-risk-reduction-in-diabetic-patients-2363https://curecurrent.com/trials/active-you-a-novel-exercise-program-for-african-americans-2364https://curecurrent.com/trials/a-clinical-trial-of-the-study-medicine-pf-07081532-in-people-with-diabetes-and-kidney-dysfunction-2365https://curecurrent.com/trials/comfortable-and-stabilizing-chin-forehead-rest-attachment-for-slit-lamp-configurations-2366https://curecurrent.com/trials/multi-center-study-to-assess-safety-tolerability-and-efficacy-of-topical-pravibismane-in-moderate-dfi-patients-2367https://curecurrent.com/trials/neoadjuvant-durvalumab-and-tremelimumab-plus-radiation-for-high-risk-soft-tissue-sarcoma-2368https://curecurrent.com/trials/cognition-in-patients-with-hypoglycemia-without-diabetes-2369https://curecurrent.com/trials/islet-cell-transplantation-alone-in-patients-with-type-1-diabetes-mellitus-steroid-free-immunosuppression-2370https://curecurrent.com/trials/quest-to-analyze-one-thousand-humans-meditating-2371https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-k-757-and-k-833-in-overweight-obese-2372https://curecurrent.com/trials/safety-and-effect-of-intravitreal-injection-of-a-derivative-of-nucleoside-reverse-transcriptase-inhibitor-in-subjects-wi-2373https://curecurrent.com/trials/resveratrol-and-vascular-function-in-ckd-2374https://curecurrent.com/trials/a-remotely-delivered-episodic-future-thinking-intervention-to-improve-management-of-type-2-diabetes-2375https://curecurrent.com/trials/a-study-to-evaluate-asp8232-in-reducing-central-retinal-thickness-in-subjects-with-diabetic-macular-edema-dme-2376https://curecurrent.com/trials/aerobic-plus-resistance-training-and-insulin-sensitivity-in-african-american-men-2377https://curecurrent.com/trials/two-bag-system-for-diabetic-ketoacidosis-2378https://curecurrent.com/trials/dietary-fatty-acids-as-complementary-therapy-in-type-2-diabetes-mellitus-2379https://curecurrent.com/trials/composition-function-of-sarcoplasmic-reticulum-in-persons-with-the-metabolic-syndrome-2380https://curecurrent.com/trials/fernald-community-cohort-18-year-observational-study-2381https://curecurrent.com/trials/hybrid-closed-loop-insulin-delivery-system-in-hypoglycemia-2382https://curecurrent.com/trials/return-of-first-phase-insulin-secretion-in-type-2-diabetes-is-associated-with-depletion-of-pancreas-lipid-2383https://curecurrent.com/trials/obesity-and-jobs-in-socioeconomically-disadvantaged-communities-a-randomized-clinical-precision-public-health-interventi-2384https://curecurrent.com/trials/diabetes-remote-intervention-to-improve-use-of-evidence-based-medications-2385https://curecurrent.com/trials/camera-qualification-study-2386https://curecurrent.com/trials/islet-transplantation-in-type-i-diabetic-patients-using-the-university-of-illinois-at-chicago-uic-protocol-2387https://curecurrent.com/trials/glycemic-response-in-persons-with-type-2-diabetes-2388https://curecurrent.com/trials/glycemic-response-in-adults-with-diabetes-2389https://curecurrent.com/trials/feasibility-of-closed-loop-automated-insulin-delivery-system-by-primary-care-endocrinology-in-person-via-telehealth-2390https://curecurrent.com/trials/twitter-and-diabetes-2391https://curecurrent.com/trials/glucose-response-in-persons-with-type-2-diabetes-2392https://curecurrent.com/trials/effectiveness-of-cgms-vs-self-monitoring-blood-glucose-smbg-in-woman-with-gestational-diabetes-2393https://curecurrent.com/trials/an-observational-study-called-first-2-0-to-learn-more-about-the-use-of-the-study-treatment-finerenone-including-how-safe-2394https://curecurrent.com/trials/the-ppcgms-intervention-after-gdm-trial-2395https://curecurrent.com/trials/remote-monitoring-of-the-diabetic-foot-to-prevent-re-ulceration-2396https://curecurrent.com/trials/cholesterol-lowering-and-residual-risk-in-type-2-diabetes-2397https://curecurrent.com/trials/gpr119-agonist-for-hypoglycemia-in-type-1-diabetes-2398https://curecurrent.com/trials/anti-inflammatory-effects-of-the-fiber-2399https://curecurrent.com/trials/effect-of-low-water-intake-on-glucose-regulation-measured-using-continuous-glucose-monitoring-2400https://curecurrent.com/trials/a-trial-examining-cellular-energetics-related-to-various-wound-treatment-therapies-2401https://curecurrent.com/trials/using-data-from-a-multisensor-rapid-health-assessment-device-to-predict-decompensation-in-long-covid-aidi-2402https://curecurrent.com/trials/randomized-controlled-multicenter-trial-of-vacuum-assisted-closure-therapy-in-diabetic-foot-ulcers-2403https://curecurrent.com/trials/evaluating-the-ease-of-use-of-a-vac-granufoam-bridge-dressing-on-diabetic-foot-ulcers-receiving-vac-negative-pressure-wo-2404https://curecurrent.com/trials/an-observational-study-called-finegust-to-learn-more-about-how-people-with-chronic-kidney-disease-and-type-2-diabetes-ar-2405https://curecurrent.com/trials/adrb3-signaling-pathway-in-human-adipose-tissue-2406https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-pre-meal-whey-protein-microgels-administration-on-post-prandial-glycemic-response-2407https://curecurrent.com/trials/effect-of-tirzepatide-on-progression-of-coronary-atherosclerosis-using-mdct-2408https://curecurrent.com/trials/a-research-trial-looking-at-the-comparability-of-2-different-concentrations-of-semaglutide-for-the-0-5-milligram-mg-dose-2409https://curecurrent.com/trials/evaluate-effects-of-sprinkled-format-reducose-in-a-carbohydrate-rich-mixed-meal-on-post-prandial-glycemia-2410https://curecurrent.com/trials/pilot-study-of-brief-intervention-to-support-diabetes-health-related-quality-of-life-2411https://curecurrent.com/trials/diabetes-homelessness-medication-support-program-in-spanish-2412https://curecurrent.com/trials/clbs201-in-patients-with-chronic-kidney-disease-ckd-and-type-2-diabetes-mellitus-t2dm-2413https://curecurrent.com/trials/integrated-behavioral-healthcare-for-youth-with-type-1-diabetes-2414https://curecurrent.com/trials/study-to-assess-safety-tolerability-and-efficacy-of-sc-administered-mbl949-in-obese-participants-with-or-without-t2dm-2415https://curecurrent.com/trials/restoring-tissue-and-evaluating-novel-treatments-for-efficacy-in-wounds-2416https://curecurrent.com/trials/stories-for-change-digital-storytelling-for-diabetes-self-management-among-hispanic-adults-2417https://curecurrent.com/trials/swift-study-of-women-infant-feeding-and-type-2-diabetes-after-gdm-pregnancy-2418https://curecurrent.com/trials/multi-site-eating-disorder-prevention-program-for-type-1-diabetes-2419https://curecurrent.com/trials/evaluation-of-a-folic-acid-wound-treatment-fawt-for-chronic-early-stage-diabetic-foot-ulcer-dfu-healing-2420https://curecurrent.com/trials/a-comparison-of-an-investigational-dressing-to-tegaderm-matrix-wound-dressing-in-the-management-of-diabetic-foot-ulcers-2421https://curecurrent.com/trials/rct-glargine-vs-nph-for-treatment-of-dm-in-pregnancy-2422https://curecurrent.com/trials/a-prospective-randomized-double-blind-multicenter-study-comparing-cdo-therapy-to-standard-mwt-in-the-treatment-of-dfus-2423https://curecurrent.com/trials/evaluating-the-benefits-of-physiologic-insulin-delivery-2424https://curecurrent.com/trials/improving-insulin-resistance-and-energy-metabolism-through-sleep-extension-in-adolescents-2425https://curecurrent.com/trials/effect-of-prebiotics-on-the-gut-microbiome-profile-and-beta-cell-function-2426https://curecurrent.com/trials/sleep-glycemic-control-and-insulin-resistance-in-adolescents-with-type-1-diabetes-2427https://curecurrent.com/trials/artificial-pancreas-and-remote-monitoring-during-a-t1dm-youth-ski-camp-2428https://curecurrent.com/trials/effect-of-a-dietary-intervention-on-insulin-requirements-in-type-1-diabetes-2429https://curecurrent.com/trials/time-restricted-eating-plus-exercise-for-weight-management-2430https://curecurrent.com/trials/prediction-of-the-sepra-diabetes-trial-in-healthcare-claims-data-2431https://curecurrent.com/trials/continuous-glucose-monitors-cgm-for-type-2-diabetes-t2d-risk-evaluation-2432https://curecurrent.com/trials/skeletal-effects-of-type-1-diabetes-on-low-trauma-fracture-risk-2433https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-rg7774-in-patients-with-diabetes-mellitus-type-1-or-type-2-with-treatm-2434https://curecurrent.com/trials/evaluation-of-didget-tm-world-reports-2435https://curecurrent.com/trials/investigating-the-relationship-between-triglycerides-and-fetal-overgrowth-in-gestational-diabetes-2436https://curecurrent.com/trials/optimizing-in-hospital-use-of-evidence-based-therapies-for-patients-with-cardio-renal-metabolic-disease-2437https://curecurrent.com/trials/evaluating-comparative-effectiveness-of-empagliflozin-in-type-2-diabetes-population-with-and-without-chronic-kidney-dise-2438https://curecurrent.com/trials/bridging-the-gap-from-postpartum-to-primary-care-2439https://curecurrent.com/trials/blood-glucose-monitoring-in-electronic-health-records-2440https://curecurrent.com/trials/using-technology-to-share-fitness-goals-and-results-to-improve-diabetes-outcomes-2441https://curecurrent.com/trials/modified-platform-trial-evaluating-pplhacm-and-soc-versus-soc-alone-in-the-treatment-of-nonhealing-dfus-2442https://curecurrent.com/trials/new-onset-diabetes-management-for-earlier-detection-of-pancreatic-cancer-nodmed-2443https://curecurrent.com/trials/a-research-study-looking-at-the-comparability-of-2-different-forms-of-oral-semaglutide-in-healthy-people-2444https://curecurrent.com/trials/household-participants-2445https://curecurrent.com/trials/heat-therapy-in-type-2-diabetes-2446https://curecurrent.com/trials/safety-and-efficacy-of-the-combination-of-empagliflozin-and-linagliptin-compared-to-linagliptin-alone-over-24-weeks-in-p-2447https://curecurrent.com/trials/impact-of-empagliflozin-on-functional-capacity-in-heart-failure-with-preserved-ejection-fraction-2448https://curecurrent.com/trials/emi-ehp-weight-management-and-type-2-diabetes-pragmatic-trial-2449https://curecurrent.com/trials/nonvisual-foot-inspection-for-people-with-visual-impairment-2450https://curecurrent.com/trials/electrical-vestibular-nerve-stimulation-vens-compared-to-sham-control-as-a-means-of-improving-glycemic-control-in-adults-2451https://curecurrent.com/trials/comparative-effectiveness-of-telemedicine-in-primary-care-2452https://curecurrent.com/trials/a-trial-to-assess-steviol-glycosides-on-acute-appetite-hormone-release-2453https://curecurrent.com/trials/comparison-of-glycemic-control-in-obese-diabetics-using-three-different-pen-needles-2454https://curecurrent.com/trials/lanifibranor-in-patients-with-type-2-diabetes-nonalcoholic-fatty-liver-disease-2455https://curecurrent.com/trials/prevalence-of-carbohydrate-intolerance-in-lean-and-overweight-obese-children-2456https://curecurrent.com/trials/using-digital-health-financial-incentives-and-community-health-worker-support-to-change-health-behavior-2457https://curecurrent.com/trials/durability-of-combination-therapy-with-exenatide-pioglitazone-metformin-vs-conventional-therapy-in-new-onset-t2dm-2458https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-intravitreal-ksi-301-in-non-proliferative-diabetic-retinopathy-npdr-2459https://curecurrent.com/trials/the-tcf7l2-gene-dietary-prevention-of-t2dm-2460https://curecurrent.com/trials/effect-of-fasting-on-hypoglycemic-counterregulation-in-type-1-diabetes-2461https://curecurrent.com/trials/diabetes-self-management-education-with-sleep-hygiene-2462https://curecurrent.com/trials/clinic-to-community-navigation-to-improve-diabetes-outcomes-2463https://curecurrent.com/trials/developing-a-model-to-predict-inpatient-hypoglycemic-episodes-2464https://curecurrent.com/trials/timing-of-insulin-before-meals-everyday-2465https://curecurrent.com/trials/multivariable-artificial-pancreas-detecting-and-mitigating-unannounced-physical-activity-and-acute-psychological-stress-2466https://curecurrent.com/trials/virtual-physical-activity-for-type-1-diabetes-2467https://curecurrent.com/trials/camp-based-multi-component-intervention-for-families-of-young-children-with-type-1-diabetes-2468https://curecurrent.com/trials/combined-diabetes-renal-multifactorial-intervention-in-patients-with-advanced-diabetic-nephropathy-adn-2469https://curecurrent.com/trials/primary-individualized-evaluation-of-cardiovascular-events-in-patients-with-diabetes-mellitus-using-hemotag-2470https://curecurrent.com/trials/an-exploratory-investigation-to-assess-changes-in-quality-of-life-for-individuals-with-type-2-diabetes-after-taking-a-me-2471https://curecurrent.com/trials/multicenter-automatic-defibrillator-implantation-trial-with-subcutaneous-implantable-cardioverter-defibrillator-2472https://curecurrent.com/trials/the-effect-of-time-restricted-eating-in-cardiometabolic-health-2473https://curecurrent.com/trials/food-as-medicine-a-quasi-randomized-control-trial-of-healthy-foods-for-chronic-disease-management-2474https://curecurrent.com/trials/a-trial-to-evaluate-the-efficacy-durability-and-safety-of-ksi-301-compared-to-aflibercept-in-participants-with-diabetic-2475https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-durability-and-safety-of-ksi-301-compared-to-aflibercept-in-participants-with-diabetic-2476https://curecurrent.com/trials/models-of-nutrition-from-continuous-glucose-monitors-2477https://curecurrent.com/trials/suvorexant-on-sleep-disturbance-in-patients-with-chronic-insomnia-and-suboptimally-controlled-type-2-diabetes-2478https://curecurrent.com/trials/promise-study-an-evaluation-of-an-implantable-continuous-glucose-sensor-up-to-180-days-2479https://curecurrent.com/trials/type-2-diabetes-prevention-in-community-health-care-settings-for-at-risk-children-and-mothers-2480https://curecurrent.com/trials/diabetes-endocrine-surveillance-in-sds-2481https://curecurrent.com/trials/n-acetyl-cysteine-nac-for-healing-of-amputation-stumps-in-the-setting-of-diabetes-2482https://curecurrent.com/trials/in-person-lifestyle-program-for-black-adolescent-girls-at-risk-for-type-2-diabetes-2483https://curecurrent.com/trials/novel-glaucoma-diagnostics-2484https://curecurrent.com/trials/couple-based-lifestyle-intervention-to-prevent-type-2-diabetes-2485https://curecurrent.com/trials/extension-for-community-health-outcomes-echo-diabetes-program-2486https://curecurrent.com/trials/dissemination-of-the-cardiovascular-risk-service-2487https://curecurrent.com/trials/exercise-and-the-receptor-for-advanced-glycation-end-products-rage-2488https://curecurrent.com/trials/effect-of-pioglitazone-on-mitochondrial-function-in-muscle-and-adipose-tissue-in-humans-2489https://curecurrent.com/trials/study-of-multiple-oral-doses-of-pf-07081532-in-adult-participants-with-type-2-diabetes-mellitus-2490https://curecurrent.com/trials/improving-diabetes-through-lifestyle-and-surgery-2491https://curecurrent.com/trials/inhale-3-afrezza-combined-with-insulin-degludec-versus-usual-care-in-adults-with-type-1-diabetes-2492https://curecurrent.com/trials/balance-control-and-recovery-in-diabetes-peripheral-neuropathy-2493https://curecurrent.com/trials/glucose-monitoring-in-youth-with-cystic-fibrosis-during-pulmonary-exacerbations-2494https://curecurrent.com/trials/effect-of-novel-glucagon-receptor-antagonist-remd-477-on-glucose-and-adipocyte-metabolism-in-t2dm-2495https://curecurrent.com/trials/preventing-diabetic-foot-ulcers-through-cleaner-feet-2496https://curecurrent.com/trials/nesvategrast-ott166-in-diabetic-retinopathy-dr-2497https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-oral-insulin-in-t2dm-patients-with-nonalcoholic-steatohepatitis-nash-2498https://curecurrent.com/trials/feasibility-of-a-decision-support-system-to-reduce-glucose-variability-in-subject-with-t1dm-2499https://curecurrent.com/trials/feasibility-and-clinical-utility-of-the-dexcom-g6-continuous-glucose-monitoring-device-for-type-2-diabetes-2500https://curecurrent.com/trials/double-blinded-randomized-control-trial-of-types-of-ivf-in-children-with-dka-2501https://curecurrent.com/trials/effect-of-nns-on-metformin-gdf15-pilot-2502https://curecurrent.com/trials/study-of-latiglutenase-in-t1d-cd-patients-2503https://curecurrent.com/trials/biological-sample-collection-for-research-and-biobanking-2504https://curecurrent.com/trials/trial-to-learn-about-the-study-medicine-pf-07081532-and-rybelsus-in-people-with-type-2-diabetes-and-separately-pf-070815-2505https://curecurrent.com/trials/family-intervention-for-chinese-americans-with-type-2-diabetes-2506https://curecurrent.com/trials/safety-and-efficacy-of-initializing-the-control-iq-artificial-pancreas-system-using-total-daily-insulin-2507https://curecurrent.com/trials/acceptability-of-self-led-mindfulness-based-intervention-2508https://curecurrent.com/trials/improving-patient-understanding-of-macrosomia-2509https://curecurrent.com/trials/effectiveness-and-safety-of-the-rightest-continuous-glucose-monitoring-system-for-blood-glucose-management-in-persons-wi-2510https://curecurrent.com/trials/a-study-of-intravitreal-iluvien-implant-as-baseline-therapy-in-patients-with-early-diabetic-macular-edema-dme-2511https://curecurrent.com/trials/use-of-continuous-glucose-monitors-in-publicly-insured-youth-with-type-2-diabetes-a-pilot-and-feasibility-study-2512https://curecurrent.com/trials/neural-net-artificial-pancreas-nap-2513https://curecurrent.com/trials/insulin-balanced-infusion-system-2514https://curecurrent.com/trials/glycemic-excursion-minimization-gem-to-outshine-health-disparities-2515https://curecurrent.com/trials/the-role-of-lipoaspirate-injection-in-the-treatment-of-diabetic-lower-extremity-wounds-and-venous-stasis-ulcers-2516https://curecurrent.com/trials/safety-evaluation-of-an-advanced-hybrid-closed-loop-system-using-lyumjev-with-the-tandem-t-slim-x2-insulin-pump-with-con-2517https://curecurrent.com/trials/isoenergetic-high-intensity-interval-training-and-moderate-intensity-training-in-adults-with-type-i-diabetes-2518https://curecurrent.com/trials/the-lobag-diet-and-type-2-diabetes-mellitus-2519https://curecurrent.com/trials/effects-of-potatoes-on-blood-pressure-in-persons-with-and-without-type-2-diabetes-who-follow-the-dash-diet-for-6-weeks-2520https://curecurrent.com/trials/community-designed-food-is-medicine-for-adults-with-diabetes-2521https://curecurrent.com/trials/lean-diabetes-study-2522https://curecurrent.com/trials/phase-1b-2-study-of-the-combination-of-imcgp100-with-durvalumab-and-or-tremelimumab-in-advanced-cutaneous-melanoma-2523https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-tolerability-of-ly3938577-in-healthy-participants-and-participants-with-type-2-dia-2524https://curecurrent.com/trials/adjunct-collection-of-additional-biorepository-data-from-patients-enrolled-in-diabetic-foot-consortium-dfc-trials-2525https://curecurrent.com/trials/evaluation-of-18-f-fp-dtbz-pancreatic-pet-scanning-as-a-tool-to-measure-beta-cell-mass-2526https://curecurrent.com/trials/a-study-to-test-the-effect-of-different-doses-of-bi-685509-on-kidney-function-in-people-with-diabetic-kidney-disease-2527https://curecurrent.com/trials/modulation-of-type-1-diabetes-susceptibility-through-the-use-of-probiotics-2528https://curecurrent.com/trials/ecc5004-ddi-study-with-atorvastatin-rosuvastatin-digoxin-and-midazolam-in-healthy-participants-2529https://curecurrent.com/trials/effects-of-saxagliptin-on-adipose-tissue-inflammation-in-humans-2530https://curecurrent.com/trials/probiotic-effect-on-dietary-nitrate-to-plasma-nitrite-production-opednpn-2531https://curecurrent.com/trials/metformin-in-heart-failure-without-diabetes-2532https://curecurrent.com/trials/family-based-lifestyle-intervention-program-and-carotenoid-supplementation-for-children-with-obesity-2533https://curecurrent.com/trials/safety-and-feasibility-of-an-insulin-sensitivity-informed-bolus-calculator-in-type-1-diabetes-2534https://curecurrent.com/trials/ftih-of-ecc5004-in-healthy-and-diabetic-participants-2535https://curecurrent.com/trials/ecc5004-rba-fe-study-in-healthy-participants-2536https://curecurrent.com/trials/developing-and-testing-a-self-compassion-tool-kit-to-improve-the-care-of-individuals-with-type-2-diabetes-2537https://curecurrent.com/trials/financial-incentives-telephone-education-and-skills-trial-in-african-americans-with-diabetes-fitest-2538https://curecurrent.com/trials/telephone-delivered-behavioral-skills-intervention-for-blacks-with-t2dm-2539https://curecurrent.com/trials/c-myc-biomarker-study-for-diabetic-foot-ulcers-2540https://curecurrent.com/trials/technology-assisted-case-management-in-adults-with-type-2-diabetes-2541https://curecurrent.com/trials/technology-delivered-diabetes-modified-behavioral-activation-treatment-2542https://curecurrent.com/trials/the-risc-registry-risk-informed-screening-registry-2543https://curecurrent.com/trials/axon-therapy-and-conventional-medical-management-for-painful-diabetic-neuropathy-compared-to-sham-and-conventional-medic-2544https://curecurrent.com/trials/a-phase-2b-diabetic-kidney-disease-study-2545https://curecurrent.com/trials/vitamin-d-and-residual-beta-cell-function-in-type-1-diabetes-2546https://curecurrent.com/trials/dexamethasone-pancreatic-clamp-p-f-2547https://curecurrent.com/trials/the-impact-of-diabetes-on-revascularization-2548https://curecurrent.com/trials/intravenous-insulin-vs-subcutaneous-insulin-infusion-in-intrapartum-management-of-type-1-diabetes-mellitus-2549https://curecurrent.com/trials/bisphenol-a-and-muscle-insulin-sensitivity-2550https://curecurrent.com/trials/stories-for-change-digital-storytelling-for-diabetes-self-management-among-somali-adults-2551https://curecurrent.com/trials/influence-of-cannabidiol-on-glucose-tolerance-and-the-gut-microbiota-2552https://curecurrent.com/trials/plant-focused-nutrition-in-patients-with-diabetes-and-chronic-kidney-disease-2553https://curecurrent.com/trials/therapy-of-the-skeletal-disease-of-type-2-diabetes-with-denosumab-2554https://curecurrent.com/trials/home-based-prediabetes-care-in-acoma-pueblo-study-1-2555https://curecurrent.com/trials/efficacy-of-human-placental-graft-in-diabetic-foot-ulcers-2556https://curecurrent.com/trials/food-rx-community-health-worker-2557https://curecurrent.com/trials/initiating-mealtime-ultra-rapid-acting-insulin-afrezza-in-uncontrolled-type-2-diabetes-patients-2558https://curecurrent.com/trials/imcy-0098-proof-of-action-in-type-1-diabetes-impact-study-2559https://curecurrent.com/trials/omeza-products-in-combination-with-standard-of-care-for-the-treatment-of-diabetic-foot-ulcers-2560https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-dapagliflozin-and-saxagliptin-in-patients-with-type-2-diabetes-mellitus-t2dm-ag-2561https://curecurrent.com/trials/reclaiming-indigenous-food-and-health-2562https://curecurrent.com/trials/well-child-visit-video-project-2563https://curecurrent.com/trials/multiple-dose-safety-and-efficacy-of-lka651-in-patients-with-diabetic-macular-edema-2564https://curecurrent.com/trials/early-administration-of-insulin-glargine-in-patients-with-diabetic-ketoacidosis-2565https://curecurrent.com/trials/navigator-1-5-accuracy-study-2566https://curecurrent.com/trials/user-performance-of-the-thunder-plus-bgms-2567https://curecurrent.com/trials/phase-2-spectra-study-to-evaluate-the-safety-and-efficacy-of-opl-0401-in-patients-with-diabetic-retinopathy-2568https://curecurrent.com/trials/dapagliflozin-at-discharge-on-hospital-heart-failure-readmission-2569https://curecurrent.com/trials/inspiratory-muscle-strength-training-in-adults-with-type-2-diabetes-2570https://curecurrent.com/trials/optimizing-outcomes-in-women-with-gestational-diabetes-mellitus-and-their-infants-2571https://curecurrent.com/trials/impact-of-sulphonylureas-on-neurodevelopmental-outcomes-in-kcnj11-related-intermediate-developmental-delay-epilepsy-and-2572https://curecurrent.com/trials/performance-of-the-l-plus-bgms-by-persons-with-diabetes-mellitus-2573https://curecurrent.com/trials/virtual-reality-as-a-dietary-education-adjunct-for-pediatric-patients-with-obesity-2574https://curecurrent.com/trials/effect-of-ketogenic-diet-on-glucose-metabolism-and-energy-expenditure-in-type-2-diabetes-2575https://curecurrent.com/trials/supplements-for-controlling-resistance-to-insulin-2576https://curecurrent.com/trials/creatine-for-treatment-of-depression-associated-with-type-2-diabetes-2577https://curecurrent.com/trials/triage-survey-for-cardiovascular-obesity-and-related-endocrine-trial-eligibility-2578https://curecurrent.com/trials/a-cognitive-behavioral-therapy-cbt-intervention-to-reduce-fear-of-hypoglycemia-in-type-1-diabetes-2579https://curecurrent.com/trials/prism-for-adolescents-with-type-1-diabetes-2580https://curecurrent.com/trials/safety-and-efficacy-of-kh-1-for-stimulating-autophagy-in-non-diabetic-adults-with-elevated-blood-glucose-concentration-2581https://curecurrent.com/trials/electronic-alerts-for-heart-failure-prevention-in-diabetes-2582https://curecurrent.com/trials/sweet-postpartum-navigation-after-gdm-2583https://curecurrent.com/trials/ctla4-ig-abatacept-for-prevention-of-abnormal-glucose-tolerance-and-diabetes-in-relatives-at-risk-for-type-1-2584https://curecurrent.com/trials/determinants-of-alpha-aminoadipic-acid-2-aaa-and-relationship-to-diabetes-study-3-2585https://curecurrent.com/trials/effects-of-semaglutide-on-intracranial-blood-flow-and-brain-barrier-permeability-in-type-2-diabetes-2586https://curecurrent.com/trials/fresh-carts-for-mom-s-to-improve-food-security-and-glucose-management-2587https://curecurrent.com/trials/intrapartum-glycemic-control-in-gdma2-2588https://curecurrent.com/trials/early-markers-of-disease-and-response-to-therapy-2589https://curecurrent.com/trials/comparing-bluedop-vascular-expert-to-ankle-brachial-index-in-the-identification-of-peripheral-vascular-disease-2590https://curecurrent.com/trials/time-in-range-using-continuous-glucose-monitoring-management-of-gestational-diabetes-mellitus-2591https://curecurrent.com/trials/hybrid-closed-loop-control-with-smart-prandial-insulin-dosing-in-type-1-diabetes-2592https://curecurrent.com/trials/program-active-ii-behavioral-depression-treatment-for-type-2-diabetes-2593https://curecurrent.com/trials/nitrate-supplementation-and-exercise-tolerance-in-patients-with-type-2-diabetes-2594https://curecurrent.com/trials/immune-effects-of-vedolizumab-with-or-without-anti-tnf-pre-treatment-in-t1d-2595https://curecurrent.com/trials/a-study-of-nasal-glucagon-ly900018-in-pediatric-participants-with-type-1-diabetes-2596https://curecurrent.com/trials/diabetes-closed-loop-project-6-dclp6-fully-automated-closed-loop-control-in-type-1-diabetes-using-meal-anticipation-2597https://curecurrent.com/trials/low-dose-il-2-in-established-t1d-the-proreg-study-2598https://curecurrent.com/trials/hornbill-a-study-to-test-different-doses-of-bi-764524-in-patients-who-have-had-laser-treatment-for-a-type-of-diabetic-ey-2599https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-obesity-or-overweight-for-the-maintenance-of-weight-loss-2600https://curecurrent.com/trials/dyslipidemia-and-diabetic-retinopathy-2601https://curecurrent.com/trials/imagine-to-remember-improving-medication-adherence-in-pre-and-type-2-diabetes-2602https://curecurrent.com/trials/clinical-investigation-of-galnobax-for-the-treatment-of-diabetic-foot-ulcers-2603https://curecurrent.com/trials/erythrocyte-and-adipocyte-g6pd-activity-levels-in-obesity-2604https://curecurrent.com/trials/dietary-supplementation-on-body-fat-composition-2605https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-after-a-lifestyle-weight-loss-program-2606https://curecurrent.com/trials/reducing-disparities-in-the-quality-of-advance-care-planning-for-older-adults-2607https://curecurrent.com/trials/safety-tolerability-and-evidence-of-activity-study-of-ubx1325-in-patients-with-diabetic-macular-edema-behold-2608https://curecurrent.com/trials/safety-and-efficacy-of-actigraft-pro-compared-to-standard-of-care-in-dfus-2609https://curecurrent.com/trials/gan-lee-insulin-glargine-target-type-1-evaluating-research-2610https://curecurrent.com/trials/reducing-emergency-diabetes-care-for-older-african-americans-2611https://curecurrent.com/trials/permissive-intrapartum-glucose-control-2612https://curecurrent.com/trials/screening-and-nutrition-for-patients-with-diabetes-a-pilot-study-2613https://curecurrent.com/trials/effects-of-novel-estrogens-on-glucose-and-lipids-in-postmenopausal-prediabetic-women-veterans-2614https://curecurrent.com/trials/study-of-pf-06882961-in-participants-with-type-2-diabetes-mellitus-with-varying-degrees-of-renal-impairment-and-particip-2615https://curecurrent.com/trials/resistance-training-in-type-1-diabetes-mellitus-2616https://curecurrent.com/trials/grocery-prescription-program-for-medicaid-adults-with-hypertension-or-type-2-diabetes-2617https://curecurrent.com/trials/vascular-endothelium-changes-after-bariatric-surgery-endothelial-progenitor-cells-2618https://curecurrent.com/trials/ultrasound-findings-in-diabetic-pregnancies-2619https://curecurrent.com/trials/extended-criteria-for-fetal-myelomeningocele-repair-2620https://curecurrent.com/trials/individualized-nutrition-therapy-for-preventing-or-delaying-onset-of-type-2-diabetes-2621https://curecurrent.com/trials/amlexanox-for-type-2-diabetes-and-obesity-2622https://curecurrent.com/trials/mitochondrial-methylation-in-type-2-diabetes-2623https://curecurrent.com/trials/tissue-repository-providing-annotated-biospecimens-for-approved-investigator-directed-biomedical-research-initiatives-2624https://curecurrent.com/trials/the-efficacy-of-intravenous-immunoglobulin-therapy-in-treatment-induced-neuropathy-of-diabetes-2625https://curecurrent.com/trials/pregsource-crowdsourcing-to-understand-pregnancy-2626https://curecurrent.com/trials/a-prospective-randomized-open-label-trial-of-two-doses-of-oral-betaine-2627https://curecurrent.com/trials/empathy-in-action-sunshine-calls-for-life-with-diabetes-2628https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-ormd-0801-in-patients-with-type-2-diabetes-mellitus-2629https://curecurrent.com/trials/evaluating-the-effectiveness-of-a-food-is-medicine-community-health-worker-program-for-pregnant-women-2630https://curecurrent.com/trials/lifestyle-intervention-feasibility-for-arrhythmia-and-symptoms-with-intermittent-fasting-life-as-if-2631https://curecurrent.com/trials/care-navigator-support-for-younger-latinx-adults-with-type-2-diabetes-2632https://curecurrent.com/trials/recurrent-hypoglycemia-in-type-1-diabetes-aim-1-2633https://curecurrent.com/trials/diabetes-outcomes-and-unmet-resources-2634https://curecurrent.com/trials/study-of-combination-of-ipilimumab-and-nivolumab-in-patients-with-melanoma-2635https://curecurrent.com/trials/cephalic-phase-responses-to-nutritive-and-non-nutritive-sweeteners-2636https://curecurrent.com/trials/evaluation-of-a-telehealth-dpp-with-medicare-patients-at-the-university-of-mississippi-medical-center-2637https://curecurrent.com/trials/a-phase-1-study-of-dd01-in-overweight-obese-subjects-with-t2dm-and-nafld-2638https://curecurrent.com/trials/text-message-based-nudges-prior-to-primary-care-visits-to-increase-care-gap-closure-2639https://curecurrent.com/trials/mir-200b-mir-21-in-diabetic-wounds-2640https://curecurrent.com/trials/biofilm-modified-macrophage-phenotype-and-function-in-diabetic-wound-healing-2641https://curecurrent.com/trials/phase-1b-2a-study-of-gsbr-1290-in-adult-overweight-or-obese-healthy-subjects-and-subjects-with-type-2-diabetes-mellitus-2642https://curecurrent.com/trials/effects-of-glp-1-agonists-on-gastric-volume-2643https://curecurrent.com/trials/topical-oxygen-therapy-for-diabetic-wounds-2644https://curecurrent.com/trials/pediatric-obesity-management-study-2645https://curecurrent.com/trials/green-digital-diabetes-waste-project-2646https://curecurrent.com/trials/care-companion-diabetes-2647https://curecurrent.com/trials/cgm-utilization-with-iv-insulin-endotool-and-subcutaneous-insulin-in-the-neuro-icu-2648https://curecurrent.com/trials/recent-onset-type-1-diabetes-trial-evaluating-efficacy-and-safety-of-teplizumab-2649https://curecurrent.com/trials/myplan-individualized-planned-eating-patterns-for-adolescents-with-type-1-diabetes-2650https://curecurrent.com/trials/automated-insulin-delivery-for-inpatients-with-dysglycemia-aiding-feasibility-2651https://curecurrent.com/trials/a-study-to-assess-11-beta-hydroxysteroid-dehydrogenase-type-1-inhibition-in-adipose-tissue-by-spi-62-2652https://curecurrent.com/trials/development-of-predictive-biomarkers-2653https://curecurrent.com/trials/safety-and-efficacy-of-vasculera-in-the-healing-of-diabetic-skin-ulcers-2654https://curecurrent.com/trials/cgm-monitoring-in-t2dm-patients-undergoing-orthopaedic-replacement-surgery-2655https://curecurrent.com/trials/at-home-research-study-for-patients-with-autoimmune-inflammatory-genetic-hematological-infectious-neurological-cns-oncol-2656https://curecurrent.com/trials/diabetes-reversal-online-program-and-study-drop-study-2657https://curecurrent.com/trials/testing-new-models-of-diabetes-self-management-to-improve-population-health-2658https://curecurrent.com/trials/comparison-of-sar341402-to-novolog-in-adult-patients-with-type-1-diabetes-mellitus-also-using-insulin-glargine-2659https://curecurrent.com/trials/naloxone-hypoglycemia-and-exercise-2660https://curecurrent.com/trials/the-hoosier-moms-cohort-2661https://curecurrent.com/trials/glp-1-receptor-agonist-therapy-and-albuminuria-in-patients-with-type-2-diabetes-2662https://curecurrent.com/trials/virtual-diabetes-specialty-clinic-a-study-evaluating-remote-initiation-of-continuous-glucose-monitoring-2663https://curecurrent.com/trials/vascular-benefits-of-adding-carvedilolcr-to-type2-diabetic-patients-on-acei-2664https://curecurrent.com/trials/glycemic-optimization-on-discharge-from-the-emergency-room-2665https://curecurrent.com/trials/the-diabetes-staging-system-in-patient-aligned-care-teams-2666https://curecurrent.com/trials/wearable-sensors-and-artificial-intelligence-for-carbohydrate-counting-2667https://curecurrent.com/trials/longitudinal-observation-of-insulin-requirements-and-sensor-use-in-pregnancy-2668https://curecurrent.com/trials/augmented-care-at-worksite-for-diabetes-prevention-2669https://curecurrent.com/trials/genomic-determinants-and-shared-genetic-pathways-of-periodontal-disease-2670https://curecurrent.com/trials/evaluation-of-a-digital-diabetes-self-management-education-and-support-program-2671https://curecurrent.com/trials/hydroxychloroquine-in-individuals-at-risk-for-type-1-diabetes-mellitus-2672https://curecurrent.com/trials/almond-butter-and-fasting-glucose-2673https://curecurrent.com/trials/daily-protein-pacing-effects-on-hba1c-in-type-2-diabetics-2674https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-type-2-diabetes-who-have-obesity-or-are-overweight-2675https://curecurrent.com/trials/continuous-glucose-monitoring-in-patients-with-end-stage-kidney-disease-and-burnt-out-diabetes-2676https://curecurrent.com/trials/a-pilot-and-feasibility-study-to-evaluate-high-vs-low-glycemic-index-mixed-meal-tolerance-test-in-adolescents-and-young-2677https://curecurrent.com/trials/adaptation-of-insulin-delivery-settings-to-improve-clinical-outcomes-with-aid-use-2678https://curecurrent.com/trials/point-of-care-testing-poct-detection-and-management-of-metabolic-syndrome-in-patients-with-mental-illness-2679https://curecurrent.com/trials/effects-of-walking-and-heating-on-vascular-function-in-diabetic-patients-2680https://curecurrent.com/trials/automated-insulin-delivery-vs-injections-sleep-impact-in-pediatric-type-1-diabetes-2681https://curecurrent.com/trials/effect-of-adiposity-on-hepatic-and-peripheral-insulin-resistance-in-type-1-diabetes-2682https://curecurrent.com/trials/cinnamon-trial-lifestyle-intervention-plus-water-soluble-cinnamon-extract-on-lowering-blood-glucose-in-pre-diabetics-2683https://curecurrent.com/trials/intermittent-calorie-restriction-insulin-resistance-and-biomarkers-of-brain-function-2684https://curecurrent.com/trials/improving-chronic-disease-management-with-pieces-2685https://curecurrent.com/trials/a-study-to-assess-the-effect-of-psyllium-vs-wheat-dextrin-on-glycemic-control-and-inflammatory-markets-in-diabetes-melli-2686https://curecurrent.com/trials/phase-2-randomized-open-label-crossover-pd-pk-study-of-a-novel-pram-insulin-co-formulation-in-adults-with-t1d-2687https://curecurrent.com/trials/a-study-of-lc542019-in-healthy-subjects-and-subjects-with-t2dm-2688https://curecurrent.com/trials/a-study-of-ly3532226-in-participants-with-type-1-diabetes-mellitus-2689https://curecurrent.com/trials/safety-and-bioactivity-of-axt107-in-subjects-with-diabetic-macular-edema-2690https://curecurrent.com/trials/almond-effects-on-glucose-intolerance-study-2691https://curecurrent.com/trials/novolog-vs-fiasp-insulin-in-non-critically-ill-hospitalized-patients-with-type-2-diabetes-mellitus-2692https://curecurrent.com/trials/gut-microbiota-short-chain-fatty-acids-and-adiposity-across-the-epidemiological-transition-2693https://curecurrent.com/trials/biothrax-anthrax-vaccine-in-pregnancy-registry-2694https://curecurrent.com/trials/angiotensin-ii-vs-vasopressin-in-septic-shock-2695https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-in-acute-heart-failure-2696https://curecurrent.com/trials/corazon-de-la-familia-heart-of-the-family-2697https://curecurrent.com/trials/improving-the-diabetic-health-of-black-men-manup-feasibility-trial-2698https://curecurrent.com/trials/trial-to-assess-continuous-glucose-monitoring-in-asian-americans-with-type-2-diabetes-2699https://curecurrent.com/trials/pharmacogenomics-of-thiazolidinediones-2700https://curecurrent.com/trials/a-clinical-trial-of-dantrolene-sodium-in-pediatric-and-adult-patients-with-wolfram-syndrome-2701https://curecurrent.com/trials/closed-incision-negative-pressure-wound-therapy-vs-foam-as-post-operative-dressing-2702https://curecurrent.com/trials/compliance-with-american-diabetes-association-treatment-guidelines-for-adult-ketoacidosis-2703https://curecurrent.com/trials/vitamin-c-and-cardiovascular-risk-2704https://curecurrent.com/trials/change-of-fructose-to-fat-in-south-asians-2705https://curecurrent.com/trials/vitamins-c-and-vitamin-e-and-cardiovascular-risk-2706https://curecurrent.com/trials/bingocize-a-novel-mobile-application-for-older-adult-health-2707https://curecurrent.com/trials/the-effects-of-two-days-of-bedrest-on-insulin-resistance-in-type-2-diabetics-2708https://curecurrent.com/trials/muscle-accrual-and-function-in-cystic-fibrosis-impact-of-glucose-intolerance-2709https://curecurrent.com/trials/culinary-medicine-vs-nutrition-education-in-diabetes-2710https://curecurrent.com/trials/communicating-health-information-and-improving-coordination-with-primary-care-2711https://curecurrent.com/trials/a-sleep-intervention-in-type-1-diabetes-2712https://curecurrent.com/trials/control-iq-technology-in-individuals-with-type-2-diabetes-2713https://curecurrent.com/trials/improving-relationships-using-motivational-interviewing-2714https://curecurrent.com/trials/preventing-diabetes-in-the-deep-south-extending-partnerships-and-adapting-interventions-to-reach-rural-communities-at-hi-2715https://curecurrent.com/trials/promoting-adolescent-investment-in-diabetes-care-2716https://curecurrent.com/trials/randomized-clinical-study-comparing-synpath-to-standard-of-care-in-treatment-of-chronic-diabetic-foot-ulcers-2717https://curecurrent.com/trials/effect-of-dapagliflozin-on-hepatic-and-renal-glucose-metabolism-subjects-2718https://curecurrent.com/trials/brain-imaging-in-the-diabetes-prevention-program-outcomes-study-2719https://curecurrent.com/trials/efficacy-of-progenamatrix-in-the-management-of-dfus-2720https://curecurrent.com/trials/effect-of-high-carbohydrate-vs-low-carbohydrate-diet-in-type-2-diabetes-2721https://curecurrent.com/trials/a-rct-to-compare-the-effects-of-two-wound-products-on-biofilm-disruption-in-dfus-2722https://curecurrent.com/trials/effects-of-single-doses-of-liraglutide-and-dapagliflozin-on-ketogenesis-in-type-1-diabetes-2723https://curecurrent.com/trials/method-comparison-user-evaluation-of-the-i-sens-self-monitoring-blood-glucose-ketone-system-2724https://curecurrent.com/trials/an-investigation-into-the-effect-of-dapagliflozin-on-ketogenesis-in-type-1-diabetes-2725https://curecurrent.com/trials/depression-in-youth-onset-type-2-diabetes-2726https://curecurrent.com/trials/effect-of-glp-1-on-insulin-biosynthesis-and-turnover-rates-2727https://curecurrent.com/trials/comparison-of-glargine-to-degludec-insulin-transition-with-or-without-a-bridging-glargine-dose-2728https://curecurrent.com/trials/covid-19-testing-in-underserved-and-vulnerable-populations-2729https://curecurrent.com/trials/effect-of-vitamin-d-on-the-honeymoon-period-in-children-and-adolescents-with-type-1-diabetes-2730https://curecurrent.com/trials/continuous-glucose-monitoring-in-dialysis-patients-to-overcome-dysglycemia-trial-2731https://curecurrent.com/trials/research-study-to-compare-semaglutide-tablets-with-empagliflozin-or-metformin-tablets-in-people-with-type-2-diabetes-2732https://curecurrent.com/trials/multi-center-prospective-randomized-controlled-trial-evaluating-skinte-in-the-treatment-of-wagner-2-dfus-2733https://curecurrent.com/trials/diabetes-discharge-transitional-cgm-study-ddt-cgm-2734https://curecurrent.com/trials/medication-adherence-clinical-decision-support-2735https://curecurrent.com/trials/the-impact-of-a-parenting-intervention-on-latino-youth-health-behaviors-2736https://curecurrent.com/trials/fruit-and-vegetable-prescription-in-the-community-health-center-setting-2737https://curecurrent.com/trials/evaluating-the-efficacy-of-a-keratin-graft-in-treating-non-healing-diabetic-foot-ulcers-2738https://curecurrent.com/trials/study-of-relacorilant-in-combination-with-pembrolizumab-for-patients-with-adrenocortical-carcinoma-which-produces-too-mu-2739https://curecurrent.com/trials/diabetes-study-of-linagliptin-and-empagliflozin-in-children-and-adolescents-dinamo-tm-2740https://curecurrent.com/trials/development-and-feasibility-testing-of-dm-boost-intervention-2741https://curecurrent.com/trials/effectiveness-of-a-diabetes-focused-discharge-order-set-among-poorly-controlled-hospitalized-patients-transitioning-to-g-2742https://curecurrent.com/trials/continuous-glucose-monitoring-initiation-at-hospital-discharge-2743https://curecurrent.com/trials/reversibility-of-brain-glucose-transport-and-metabolism-in-t2dm-an-intervention-study-2744https://curecurrent.com/trials/very-low-carbohydrate-diet-as-an-adjunctive-therapy-for-youth-type-1-diabetes-2745https://curecurrent.com/trials/um-crmc-recur-score-pilot-2746https://curecurrent.com/trials/omnipod-horizon-automated-glucose-control-system-preschool-cohort-2747https://curecurrent.com/trials/safety-effectiveness-of-duodenal-mucosal-resurfacing-dmr-using-the-revita-system-in-treatment-of-type-2-diabetes-2748https://curecurrent.com/trials/my-dose-coach-mobile-app-to-support-insulin-titration-and-maintenance-2749https://curecurrent.com/trials/2-a-day-study-twice-a-day-meals-study-2750https://curecurrent.com/trials/the-effect-of-bolus-speed-of-rapid-acting-insulin-analog-absorption-and-action-in-individuals-with-type-1-diabetes-2751https://curecurrent.com/trials/precision-study-multi-center-study-of-performance-of-a-novel-implanted-cgm-system-using-a-next-generation-transmitter-an-2752https://curecurrent.com/trials/the-project-wellness-pilot-feasibility-randomized-controlled-trial-2753https://curecurrent.com/trials/reverse-innovation-and-patient-engagement-to-improve-quality-of-care-and-patient-outcomes-2754https://curecurrent.com/trials/effect-of-subcutaneous-semaglutide-on-kidney-transplant-candidacy-2755https://curecurrent.com/trials/online-diabetes-education-project-odep-2756https://curecurrent.com/trials/micro-clinic-obesity-and-metabolic-risk-prevention-program-2757https://curecurrent.com/trials/study-of-re-doctor-vitals-software-accuracy-2758https://curecurrent.com/trials/multiple-escalating-oral-doses-study-of-pf-07081532-in-adult-participants-with-type-2-diabetes-mellitus-2759https://curecurrent.com/trials/shared-medical-decision-making-in-pediatric-diabetes-2760https://curecurrent.com/trials/enhancing-diabetes-and-hypertension-self-management-rural-appalachian-patients-in-patient-centered-medical-homes-2761https://curecurrent.com/trials/microalbuminuria-in-children-with-and-without-diabetes-2762https://curecurrent.com/trials/nu-3-topical-gel-for-treatment-of-diabetic-foot-ulcer-2763https://curecurrent.com/trials/bva-200-vs-bva-100-validation-study-2764https://curecurrent.com/trials/phase-1-open-label-safety-study-of-umbilical-cord-lining-mesenchymal-stem-cells-corlicyte-to-heal-chronic-diabetic-foot-2765https://curecurrent.com/trials/overcoming-therapeutic-inertia-among-adults-recently-diagnosed-with-type-2-diabetes-2766https://curecurrent.com/trials/weight-loss-in-chronic-disease-patient-population-2767https://curecurrent.com/trials/study-to-assess-the-effects-of-fx006-on-blood-glucose-in-patients-with-oa-of-the-knee-and-type-2-diabetes-2768https://curecurrent.com/trials/dapagliflozin-as-additional-treatment-to-liraglutide-and-insulin-in-patients-with-type-1-diabetes-2769https://curecurrent.com/trials/peer-delivered-and-technology-assisted-integrated-illness-management-and-recovery-2770https://curecurrent.com/trials/liraglutide-in-type-1-diabetes-2771https://curecurrent.com/trials/dapagliflozin-effects-on-hypoglycemia-2772https://curecurrent.com/trials/weight-management-for-the-remission-of-type-2-diabetes-using-a-proprietary-meal-replacement-system-diabetes-remission-st-2773https://curecurrent.com/trials/mobile-phone-support-for-adults-and-support-persons-to-live-well-with-diabetes-2774https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-healthy-participants-and-participants-with-type-2-diabetes-t2dm-2775https://curecurrent.com/trials/reversal-of-obese-diabetic-cardiomyopathy-after-gastric-bypass-surgery-2776https://curecurrent.com/trials/nutritional-therapy-for-diabetic-cardiomyopathy-2777https://curecurrent.com/trials/a-study-of-ly3457263-alone-and-in-combination-with-dulaglutide-ly2189265-in-participants-with-type-2-diabetes-2778https://curecurrent.com/trials/combined-vaginal-misoprostol-and-perivascular-vasopressin-2779https://curecurrent.com/trials/ph-2a-study-of-hu6-on-energy-metabolism-muscle-and-liver-substrate-metabolism-and-mitochondrial-function-in-subjects-who-2780https://curecurrent.com/trials/an-observational-study-called-flamingo-to-learn-more-about-the-treatment-combination-of-finerenone-and-sglt2-inhibitors-2781https://curecurrent.com/trials/a-study-to-measure-stomach-emptying-in-overweight-non-diabetic-and-diabetic-participants-using-tirzepatide-2782https://curecurrent.com/trials/the-influence-of-glycemic-control-and-obesity-on-energy-balance-and-metabolic-flexibility-in-type-1-diabetes-2783https://curecurrent.com/trials/sirolimus-to-treat-diabetic-macular-edema-2784https://curecurrent.com/trials/sglt2-inhibition-in-older-obese-adults-with-pre-diabetes-2785https://curecurrent.com/trials/liraglutide-in-the-treatment-of-type-1-diabetes-mellitus-2786https://curecurrent.com/trials/study-to-assess-efficacy-safety-of-reparixin-in-pancreatic-islet-transplantation-2787https://curecurrent.com/trials/social-media-use-in-adolescent-diabetes-care-2788https://curecurrent.com/trials/a-study-to-assess-the-effect-of-smart-insulin-pens-on-glycemic-control-and-diabetes-related-burdens-2789https://curecurrent.com/trials/managing-insulin-with-a-voice-ai-2790https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-lidoderm-as-add-on-treatment-in-patients-with-postherpetic-neuralgia-diabetic-2791https://curecurrent.com/trials/a-study-of-lidocaine-patch-5-alone-gabapentin-alone-and-lidocaine-patch-5-and-gabapentin-in-combination-for-the-relief-o-2792https://curecurrent.com/trials/teen-heed-an-adolescent-diabetes-prevention-intervention-incorporating-novel-mobile-health-technologies-2793https://curecurrent.com/trials/fluctuation-reduction-with-insulin-and-glp-1-added-together-flat-sugar-2794https://curecurrent.com/trials/effects-of-sglt-2-inhibition-on-myocardial-fibrosis-and-inflammation-as-assessed-by-cardiac-mri-in-patients-with-dm2-2795https://curecurrent.com/trials/sglt2-inhibitor-effects-on-inflammation-and-heart-disease-in-obesity-pilot-2796https://curecurrent.com/trials/shared-medical-visits-for-spanish-speaking-patients-with-type-2-diabetes-2797https://curecurrent.com/trials/metabolic-effects-of-hydroxychloroquine-2798https://curecurrent.com/trials/triamcinolone-vs-laser-for-diabetic-macular-edema-2799https://curecurrent.com/trials/comparison-of-blood-pressure-medications-on-metabolism-2800https://curecurrent.com/trials/endogenous-glp-1-secretion-on-islet-function-in-people-with-and-without-type-2-diabetes-2801https://curecurrent.com/trials/post-operative-complications-and-graft-survival-with-conventional-versus-continuous-glucose-monitoring-in-patients-with-2802https://curecurrent.com/trials/multicenter-trial-of-the-effect-of-aat-on-islet-transplant-engraftment-and-durability-after-renal-transplant-2803https://curecurrent.com/trials/ladarixin-as-adjunctive-therapy-to-improve-insulin-sensitivity-and-glucometabolic-outcomes-in-type-1-diabetes-2804https://curecurrent.com/trials/cadaveric-islet-transplantation-in-patients-with-insulin-dependent-diabetes-mellitus-2805https://curecurrent.com/trials/determinants-of-alpha-aminoadipic-acid-2-aaa-and-relationship-to-diabetes-study-2-2806https://curecurrent.com/trials/telehealth-and-meal-replacement-pilot-program-for-patients-with-diabetes-2807https://curecurrent.com/trials/effect-of-alpelisib-in-healthy-volunteers-2808https://curecurrent.com/trials/salivary-glycated-albumin-2809https://curecurrent.com/trials/protege-encore-study-clinical-trial-of-teplizumab-mga031-in-children-and-adults-with-recent-onset-type-1-diabetes-mellit-2810https://curecurrent.com/trials/cloudconnect-predictive-and-retrospective-clinical-decision-support-for-chronic-disease-management-2811https://curecurrent.com/trials/telemedicine-for-reach-education-access-and-treatment-ongoing-2812https://curecurrent.com/trials/assessment-of-retinal-fundus-imaging-camera-2813https://curecurrent.com/trials/smart-goals-for-youth-with-prediabetes-2814https://curecurrent.com/trials/evaluating-metabolic-mechanisms-of-ertugliflozin-in-diabetes-heart-failure-2815https://curecurrent.com/trials/incidence-and-predictors-of-acute-and-chronic-complications-in-patients-with-diabetes-and-severe-covid-19-2816https://curecurrent.com/trials/ctsi-pilot-improving-adherence-to-diabetic-diet-2817https://curecurrent.com/trials/patientspot-formerly-known-as-arthritispower-2818https://curecurrent.com/trials/simplified-insulin-regimen-for-the-elderly-2819https://curecurrent.com/trials/effects-of-almonds-on-glycemia-in-adults-with-elevated-hemoglobin-a1c-concentrations-2820https://curecurrent.com/trials/zinc-supplementation-improves-cardiovascular-morbidity-in-patients-with-diabetes-mellitus-2821https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-of-anti-aging-pro-autophagy-effects-of-metformin-in-adults-with-prediabetes-2822https://curecurrent.com/trials/skeletal-muscle-health-in-children-with-type-1-diabetes-2823https://curecurrent.com/trials/safety-and-efficacy-of-the-noxsano-wound-care-bandage-2824https://curecurrent.com/trials/comrade-collaborative-care-management-for-distress-and-depression-in-rural-diabetes-2825https://curecurrent.com/trials/diabetes-pump-with-predictive-low-glucose-suspend-pivotal-trial-2826https://curecurrent.com/trials/the-national-diabetes-prevention-program-in-rural-communities-2827https://curecurrent.com/trials/control-iq-observational-clio-post-approval-study-2828https://curecurrent.com/trials/a-prospective-randomised-double-blind-double-dummy-forced-titration-multicentre-parallel-group-one-year-treatment-trial-2829https://curecurrent.com/trials/improving-diabetes-equity-and-advancing-care-study-2830https://curecurrent.com/trials/mindfulness-training-in-adolescents-with-type-1-diabetes-2831https://curecurrent.com/trials/vascular-endothelial-growth-factor-b-vegf-b-blockade-with-the-monoclonal-antibody-csl346-in-subjects-with-diabetic-kidne-2832https://curecurrent.com/trials/peer-support-for-patients-with-diabetic-foot-ulcers-2833https://curecurrent.com/trials/a-prospective-pilot-study-evaluating-the-effect-of-cataract-surgery-on-the-daily-activity-levels-of-elderly-patients-2834https://curecurrent.com/trials/timing-of-ambulation-and-infant-birth-weight-in-gestational-diabetes-2835https://curecurrent.com/trials/dhs-mind-metabolomics-2836https://curecurrent.com/trials/the-prot-g-study-clinical-trial-of-mga031-in-children-and-adults-with-recent-onset-type-1-diabetes-mellitus-2837https://curecurrent.com/trials/clinical-trial-to-assess-the-effects-of-dairy-on-insulin-sensitivity-and-cell-function-2838https://curecurrent.com/trials/analysis-of-b-cells-from-autoimmune-individuals-2839https://curecurrent.com/trials/a-study-of-the-incidence-of-intraocular-inflammation-and-suspected-endophthalmitis-among-patients-treated-with-afliberce-2840https://curecurrent.com/trials/preclinical-imaging-biomarkers-of-alzheimer-s-disease-neuropathology-in-young-adults-with-youth-onset-diabetes-a-proof-o-2841https://curecurrent.com/trials/effect-of-farxiga-on-renal-function-and-size-in-type-2-diabetic-patients-with-hyperfiltration-2842https://curecurrent.com/trials/continuous-glucose-monitoring-and-hass-avocado-trial-chat-2843https://curecurrent.com/trials/effects-of-a-computerized-physician-order-entry-cpoe-based-inpatient-insulin-protocol-on-glycemic-outcomes-2844https://curecurrent.com/trials/pregnancy-intervention-with-a-closed-loop-system-picls-study-2845https://curecurrent.com/trials/a-study-to-evaluate-thr-149-treatment-for-diabetic-macular-oedema-2846https://curecurrent.com/trials/barley-beta-glucan-glycemic-control-and-appetite-2847https://curecurrent.com/trials/a-phase-i-study-of-episcleral-dexamethasone-for-treatment-of-macular-edema-2848https://curecurrent.com/trials/collaborative-depression-care-management-in-treating-depressed-low-income-hispanics-with-diabetes-2849https://curecurrent.com/trials/mobile-health-app-to-reduce-diabetes-in-latina-women-with-prior-gestational-diabetes-ii-2850https://curecurrent.com/trials/adolescent-type-1-diabetes-treatment-with-sglt2i-for-hyperglycemia-hyperfiltration-trial-2851https://curecurrent.com/trials/prenatal-and-obstetric-maternal-exposures-and-islet-autoantibodies-in-early-life-2852https://curecurrent.com/trials/detec-ph-point-of-care-wound-diagnostic-test-2853https://curecurrent.com/trials/a-study-of-oral-glp1ra-rgt001-075-in-adults-with-type-2-diabetes-2854https://curecurrent.com/trials/prospective-multicenter-rct-of-the-tenex-ultrasound-system-2855https://curecurrent.com/trials/peers-excel-trial-to-improve-glycemic-control-2856https://curecurrent.com/trials/incretin-action-in-physiology-and-diabetes-2857https://curecurrent.com/trials/a-comparison-of-slx-4090-in-combination-with-metformin-versus-metformin-therapy-alone-in-patients-with-type-2-diabetes-2858https://curecurrent.com/trials/progression-and-etiology-of-cortical-porosity-in-diabetic-bone-disease-2859https://curecurrent.com/trials/detec-esterase-for-screening-wound-infection-at-point-of-care-2860https://curecurrent.com/trials/study-of-kd026-in-combination-with-metformin-in-subjects-with-type-2-diabetes-mellitus-2861https://curecurrent.com/trials/pilot-study-evaluating-the-acceptability-and-absorption-of-the-bioactive-compounds-of-a-russian-tarragon-nutrasorb-bar-2862https://curecurrent.com/trials/cholesterol-hypertension-and-glucose-education-study-2863https://curecurrent.com/trials/diabetes-communication-and-treatment-burden-2864https://curecurrent.com/trials/treatment-of-glp-1-for-diabetic-bariatric-patients-2865https://curecurrent.com/trials/nonvisual-foot-examination-for-people-with-diabetes-and-visual-impairment-2866https://curecurrent.com/trials/prepivotal-omnipod-horizon-automated-glucose-control-system-2867https://curecurrent.com/trials/dexcom-continuous-glucose-monitoring-in-long-term-care-2868https://curecurrent.com/trials/continuous-glucose-monitoring-system-cgm-informed-bolus-calculator-study-2869https://curecurrent.com/trials/influence-of-osmotic-stimulation-of-vasopressin-on-autonomic-function-2870https://curecurrent.com/trials/comparative-effectiveness-of-metformin-for-type-2-diabetes-with-chronic-kidney-disease-2871https://curecurrent.com/trials/enhanced-quality-in-primary-care-for-elders-with-diabetes-and-dementia-2872https://curecurrent.com/trials/social-work-intervention-focused-on-transitions-2873https://curecurrent.com/trials/long-term-study-of-nateglinide-valsartan-to-prevent-or-delay-type-ii-diabetes-mellitus-and-cardiovascular-complications-2874https://curecurrent.com/trials/efficacy-and-safety-of-aeye-ds-software-device-for-automated-detection-of-diabetic-retinopathy-from-digital-funduscopic-2875https://curecurrent.com/trials/a-study-to-evaluate-pneumococcal-polysaccharide-vaccine-effectiveness-in-children-with-type-1-diabetes-2876https://curecurrent.com/trials/examination-of-psychological-tools-and-tracking-in-an-online-intervention-for-type-2-diabetes-2877https://curecurrent.com/trials/rapid-non-invasive-regional-functional-imaging-of-the-retina-diabetic-retinopathy-diagnosis-device-2878https://curecurrent.com/trials/outpatient-cervical-ripening-with-orally-administered-misoprostol-in-diabetics-2879https://curecurrent.com/trials/exercise-training-and-metabolic-flexibility-in-prediabetes-2880https://curecurrent.com/trials/insulin-glargine-versus-twice-daily-nph-2881https://curecurrent.com/trials/diabetes-complication-control-in-community-clinics-d4c-trial-2882https://curecurrent.com/trials/initiate-plus-initiation-of-insulin-to-reach-a1c-target-study-2883https://curecurrent.com/trials/the-effects-of-work-schedule-and-sleep-patterns-on-caregivers-health-2884https://curecurrent.com/trials/intervention-mapping-to-adapt-a-mindfulness-based-intervention-for-adults-with-diabetes-and-emotional-distress-2885https://curecurrent.com/trials/access-ai-for-pediatric-diabetic-eye-exams-study-2886https://curecurrent.com/trials/eimpact-dm-pilot-trial-depression-treatment-to-reduce-diabetes-risk-2887https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-versus-insulin-lispro-u100-in-participants-with-type-2-diabetes-inadequately-controlled-2888https://curecurrent.com/trials/glucose-monitoring-to-predict-and-treat-high-glucose-levels-after-steroid-treatment-2889https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-oral-akst4290-in-participants-with-moderately-severe-to-severe-diabetic-retinopathy-2890https://curecurrent.com/trials/a-cognitive-behavioral-digital-therapeutic-intervention-for-glycemic-control-in-type-2-diabetes-mellitus-2891https://curecurrent.com/trials/the-impact-of-food-order-on-glycemic-excursions-in-type-2-diabetes-assessed-by-continuous-glucose-monitoring-2892https://curecurrent.com/trials/digital-therapeutic-based-investigation-to-improve-glycemic-control-in-patients-with-type-2-diabetes-and-residual-hyperg-2893https://curecurrent.com/trials/go-girls-fitness-support-group-intervention-effectiveness-study-2894https://curecurrent.com/trials/revealing-engagement-dynamics-among-diabetic-kidney-disease-patients-2895https://curecurrent.com/trials/dexcom-g6-intervention-study-2896https://curecurrent.com/trials/fenofibrate-in-type-2-diabetes-2897https://curecurrent.com/trials/translating-the-diabetes-prevention-program-dpp-lifestyle-intervention-to-rural-african-american-communities-healthy-way-2898https://curecurrent.com/trials/diabetic-foot-ulcer-recurrence-pilot-study-2899https://curecurrent.com/trials/behavioral-family-therapy-and-type-one-diabetes-2900https://curecurrent.com/trials/a-study-of-u-500-insulin-ly041001-in-participants-with-type-2-diabetes-2901https://curecurrent.com/trials/integrated-intervention-for-breast-cancer-survivors-with-diabetes-2902https://curecurrent.com/trials/tebipenem-spr994-tissue-penetration-in-diabetic-patients-with-wound-infections-and-healthy-volunteers-via-in-vivo-microd-2903https://curecurrent.com/trials/sarcopenic-obesity-in-the-elderly-2904https://curecurrent.com/trials/a-trial-to-assess-diets-containing-beef-vs-poultry-on-pancreatic-beta-cell-function-2905https://curecurrent.com/trials/a-study-to-evaluate-safety-engraftment-and-efficacy-of-vc-01-in-subjects-with-t1-diabetes-mellitus-2906https://curecurrent.com/trials/integrating-solution-focused-interventions-in-integrated-care-2907https://curecurrent.com/trials/a-12-week-study-of-topical-pirenzepine-or-placebo-in-type-2-diabetic-patients-t2dm-with-painful-peripheral-neuropathy-2908https://curecurrent.com/trials/a-study-of-ly3502970-in-participants-with-type-2-diabetes-mellitus-2909https://curecurrent.com/trials/diabetes-prevention-for-mexican-americans-2910https://curecurrent.com/trials/effect-of-mobile-phone-telemedicine-on-diabetes-care-2911https://curecurrent.com/trials/diabetes-management-program-for-hispanic-latino-2912https://curecurrent.com/trials/validation-study-of-retina-ai-galaxy-v2-0-an-automated-diabetic-retinopathy-screening-device-2913https://curecurrent.com/trials/implementing-a-mobile-health-application-for-hiv-infected-and-uninfected-women-with-co-morbidities-in-the-outpatient-set-2914https://curecurrent.com/trials/effect-of-an-extract-of-green-tea-on-adults-with-type-2-diabetes-2915https://curecurrent.com/trials/the-effect-of-donepezil-on-glycemic-control-in-type-ii-diabetics-2916https://curecurrent.com/trials/nutri-diet-goal-setting-software-pilot-trial-2917https://curecurrent.com/trials/loop-t2d-observational-study-2918https://curecurrent.com/trials/microbiome-insulin-sensitivity-study-2919https://curecurrent.com/trials/the-prospective-evaluation-of-pancreatic-function-in-pancreas-transplant-recipients-2920https://curecurrent.com/trials/food-and-education-effects-on-diabetes-study-2921https://curecurrent.com/trials/metabolomics-of-roux-en-y-gastric-bypass-rygb-with-gastrostomy-2922https://curecurrent.com/trials/pathway-for-produce-prescriptions-in-diabetes-management-2923https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-k-757-and-k-833-in-overweight-obese-patients-wit-2924https://curecurrent.com/trials/semaglutide-treatment-on-coronary-progression-2925https://curecurrent.com/trials/biorepository-of-biospecimen-samples-in-matched-healthy-control-participants-and-participants-diagnosed-with-diabetic-ki-2926https://curecurrent.com/trials/vascular-risk-after-kidney-transplantation-2927https://curecurrent.com/trials/effect-of-natrox-oxygen-wound-therapy-on-non-healing-wounds-and-implication-of-remote-monitoring-and-telehealth-for-mana-2928https://curecurrent.com/trials/comparing-synthetic-hybrid-scale-fiber-matrix-with-standard-of-care-in-treating-diabetic-foot-ulcers-2929https://curecurrent.com/trials/use-of-an-investigational-digital-therapeutic-in-patients-with-type-2-diabetes-2930https://curecurrent.com/trials/pivotal-trial-of-a-digital-therapeutic-for-the-treatment-of-type-2-diabetes-2931https://curecurrent.com/trials/characteristics-of-non-diabetic-hyperglycemic-inpatients-2932https://curecurrent.com/trials/benefits-of-insulin-supplementation-for-correction-of-hyperglycemia-in-patients-with-type-2-diabetes-2933https://curecurrent.com/trials/determine-detemir-vs-nph-2934https://curecurrent.com/trials/study-of-pembrolizumab-given-with-ipilimumab-or-placebo-in-participants-with-untreated-metastatic-non-small-cell-lung-ca-2935https://curecurrent.com/trials/assessment-of-sleep-and-sleep-disruptors-in-adolescents-with-type-1-diabetes-2936https://curecurrent.com/trials/cocoa-and-metabolic-health-in-prediabetes-2937https://curecurrent.com/trials/yh001-plus-envafolimab-with-or-without-doxorubicin-in-patients-with-advanced-or-metastatic-sarcoma-2938https://curecurrent.com/trials/a-study-using-surveys-to-learn-more-about-treatment-with-steroidal-mineralocorticoid-receptor-antagonists-how-they-are-u-2939https://curecurrent.com/trials/diabetes-survival-skills-dss-training-intervention-for-incarcerated-persons-transitioning-to-the-community-ttc-2940https://curecurrent.com/trials/randomized-trial-of-telemedicine-for-diabetes-care-2941https://curecurrent.com/trials/afrezza-dosing-optimization-study-2942https://curecurrent.com/trials/the-effect-of-insulin-glulisine-compared-with-insulin-aspart-on-breakfast-post-prandial-glucose-levels-in-prepubertal-ch-2943https://curecurrent.com/trials/an-add-on-study-to-the-figaro-dkd-study-called-figaro-bm-to-learn-about-the-link-between-biomarkers-substances-in-the-bl-2944https://curecurrent.com/trials/cgm-use-in-children-with-type-2-diabetes-2945https://curecurrent.com/trials/vascular-risk-progression-in-normal-and-diabetic-control-subjects-2946https://curecurrent.com/trials/mobile-application-to-create-healthy-food-preparation-habits-for-patients-with-diabetes-and-prediabetes-2947https://curecurrent.com/trials/a-study-of-a-personalized-cancer-vaccine-targeting-shared-neoantigens-2948https://curecurrent.com/trials/using-sitagliptin-as-a-treatment-to-prevent-new-onset-diabetes-after-kidney-transplantation-2949https://curecurrent.com/trials/a-study-of-a-personalized-neoantigen-cancer-vaccine-2950https://curecurrent.com/trials/diabetes-management-in-low-income-hispanic-patients-2951https://curecurrent.com/trials/inflammation-inhibition-in-prediabetic-humans-2952https://curecurrent.com/trials/balanced-egg-protein-during-obesity-reduction-differential-responses-of-insulin-resistance-by-race-2953https://curecurrent.com/trials/use-of-ac5-advanced-wound-system-in-the-treatment-of-diabetic-foot-ulcers-2954https://curecurrent.com/trials/the-impact-of-sexual-health-and-amputation-focused-education-on-regulation-of-glucose-and-amputation-prevention-2955https://curecurrent.com/trials/impact-of-acetaminophen-on-performance-of-guardian-sensor-3-in-adults-2956https://curecurrent.com/trials/the-effect-of-kombucha-on-blood-sugar-levels-in-humans-2957https://curecurrent.com/trials/ideglira-high-trial-2958https://curecurrent.com/trials/diabetes-prevention-program-pilot-2959https://curecurrent.com/trials/glucose-counterregulation-in-long-standing-type-1-diabetes-2960https://curecurrent.com/trials/adapting-and-assessing-the-feasibility-of-a-diabetes-self-management-telehealth-intervention-2961https://curecurrent.com/trials/continuous-glucose-monitoring-during-and-after-surgery-2962https://curecurrent.com/trials/gender-differences-in-prevalence-of-undiagnosed-diabetes-in-acs-2963https://curecurrent.com/trials/ped-neonat-20-000599-fetal-body-composition-2964https://curecurrent.com/trials/hybrid-closed-loop-in-high-risk-youth-with-type-1-diabetes-2965https://curecurrent.com/trials/distal-peripheral-neuropathy-in-type-2-diabetes-2966https://curecurrent.com/trials/sdrm-vs-collagen-for-diabetic-foot-ulcers-2967https://curecurrent.com/trials/the-cgms-in-gdm-labor-and-delivery-study-2968https://curecurrent.com/trials/neuropsychological-consultation-as-part-of-pediatric-diabetes-care-does-it-improve-glycemic-control-and-family-functioni-2969https://curecurrent.com/trials/clinical-study-of-allo-asc-sheet-in-subjects-with-diabetic-wagner-grade-ii-foot-ulcers-2970https://curecurrent.com/trials/effect-of-panretinal-photocoagulation-on-optic-nerve-head-topography-2971https://curecurrent.com/trials/closed-loop-control-in-adolescents-using-heart-rate-as-exercise-indicator-2972https://curecurrent.com/trials/impact-of-chronic-kidney-disease-on-clopidogrel-effects-in-diabetes-mellitus-2973https://curecurrent.com/trials/effect-of-renin-angiotensin-system-blockade-on-urinary-free-light-chains-in-patients-with-type-2-diabetes-mellitus-2974https://curecurrent.com/trials/targeting-physical-activity-to-improve-cardiovascular-health-in-type-2-diabetes-2975https://curecurrent.com/trials/daily-blood-glucose-trends-in-patients-at-risk-for-diabetes-2976https://curecurrent.com/trials/the-effect-of-potatoes-on-markers-of-cardiometabolic-health-2977https://curecurrent.com/trials/pistachios-blood-sugar-control-heart-and-gut-health-2978https://curecurrent.com/trials/peanuts-and-glycemic-control-2979https://curecurrent.com/trials/a-study-to-evaluate-thr-687-treatment-for-diabetic-macular-oedema-2980https://curecurrent.com/trials/time-limited-eating-in-type-1-diabetes-2981https://curecurrent.com/trials/behavioral-economics-applications-to-geriatrics-leveraging-ehrs-r33-trial-2982https://curecurrent.com/trials/renal-heir-study-renal-hemodynamics-energetics-and-insulin-resistance-in-youth-onset-type-2-diabetes-study-2983https://curecurrent.com/trials/pioglitazone-and-insulin-resistance-in-adt-2984https://curecurrent.com/trials/exercise-snacks-and-glutamine-to-improve-glucose-control-in-adolescents-with-type-1-diabetes-2985https://curecurrent.com/trials/effects-of-fos-biomedical-device-on-diabetes-risk-factors-and-sleep-quality-in-adults-at-risk-for-type-2-diabetes-2986https://curecurrent.com/trials/strong-men-strong-communities-diabetes-risk-reduction-in-american-indian-men-2987https://curecurrent.com/trials/managing-diabetes-mindfully-study-2988https://curecurrent.com/trials/a-pilot-study-of-a-low-glycemic-load-diet-in-adults-with-cystic-fibrosis-2989https://curecurrent.com/trials/protege-extension-trial-long-term-follow-up-trial-for-subjects-who-completed-the-protege-study-cp-mga031-01-2990https://curecurrent.com/trials/mhealth-insulin-titration-and-management-isage-2991https://curecurrent.com/trials/encouraging-mail-order-pharmacy-use-to-improve-outcomes-and-reduce-disparities-2992https://curecurrent.com/trials/novel-biomarker-for-development-of-t2d-2993https://curecurrent.com/trials/study-of-an-interstitial-fluid-glucose-sensor-2994https://curecurrent.com/trials/cgm-use-in-poorly-controlled-youth-with-type-1-diabetes-2995https://curecurrent.com/trials/cgm-use-in-covid19-patients-infection-with-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-2996https://curecurrent.com/trials/automated-insulin-delivery-in-pregnant-patients-with-type-1-diabetes-with-extension-into-outpatient-at-home-2997https://curecurrent.com/trials/family-health-history-in-diverse-care-settings-fhh-2998https://curecurrent.com/trials/look-ahead-action-for-health-in-diabetes-2999https://curecurrent.com/trials/cognitive-behavioral-therapy-for-african-americans-with-uncontrolled-type-2-diabetes-3000